<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" dtd-version="1.3" xml:lang="EN" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Inorg Chem</journal-id><journal-id journal-id-type="iso-abbrev">Inorg Chem</journal-id><journal-id journal-id-type="publisher-id">ic</journal-id><journal-id journal-id-type="coden">inocaj</journal-id><journal-title-group><journal-title>Inorganic Chemistry</journal-title></journal-title-group><issn pub-type="ppub">0020-1669</issn><issn pub-type="epub">1520-510X</issn><publisher><publisher-name>American Chemical Society</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39945504</article-id><article-id pub-id-type="pmc">PMC11863378</article-id>
<article-id pub-id-type="doi">10.1021/acs.inorgchem.4c04823</article-id><article-categories><subj-group><subject>Article</subject></subj-group></article-categories><title-group><article-title>A Half-Sandwich
Os(II) Glucoconjugated NHC Complex
as a Modulator of Amyloid Aggregation</article-title></title-group><contrib-group><contrib contrib-type="author" id="ath1"><name><surname>Florio</surname><given-names>Daniele</given-names></name><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author" corresp="yes" id="ath2"><name><surname>Annunziata</surname><given-names>Alfonso</given-names></name><xref rid="cor1" ref-type="other">*</xref><xref rid="aff2" ref-type="aff">b</xref><xref rid="notes2" ref-type="notes">&#x02020;</xref></contrib><contrib contrib-type="author" id="ath3"><name><surname>Panzetta</surname><given-names>Valeria</given-names></name><xref rid="aff3" ref-type="aff">c</xref><xref rid="aff4" ref-type="aff">d</xref></contrib><contrib contrib-type="author" id="ath4"><name><surname>Netti</surname><given-names>Paolo A.</given-names></name><xref rid="aff3" ref-type="aff">c</xref><xref rid="aff4" ref-type="aff">d</xref></contrib><contrib contrib-type="author" id="ath5"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-1624-079X</contrib-id><name><surname>Ruffo</surname><given-names>Francesco</given-names></name><xref rid="aff2" ref-type="aff">b</xref></contrib><contrib contrib-type="author" corresp="yes" id="ath6"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-6618-2949</contrib-id><name><surname>Marasco</surname><given-names>Daniela</given-names></name><xref rid="cor2" ref-type="other">*</xref><xref rid="aff5" ref-type="aff">e</xref></contrib><aff id="aff1"><label>a</label><institution>IRCCS SYNLAB
SDN</institution>, Via G., Ferraris
144, Naples 80146, <country>Italy</country></aff><aff id="aff2"><label>b</label>Department
of Chemical Sciences, <institution>University of Naples
Federico II</institution>, Naples 80126, <country>Italy</country></aff><aff id="aff3"><label>c</label>Department
of Chemical, Materials, and Industrial Production Engineering (DICMaPI), <institution>University of Naples Federico II</institution>, Naples 80125, <country>Italy</country></aff><aff id="aff4"><label>d</label>Interdisciplinary
Research Centre on Biomaterials (CRIB), <institution>University of Naples Federico II, Istituto Italiano di Tecnologia</institution>, Naples 80125, <country>Italy</country></aff><aff id="aff5"><label>e</label>Department
of Pharmacy, <institution>University of Naples Federico
II</institution>, Naples 80131, <country>Italy</country></aff></contrib-group><author-notes><corresp id="cor1"><label>*</label>Email: <email>alfonso.annunziata@imdea.org</email>.</corresp><corresp id="cor2"><label>*</label>Email: <email>daniela.marasco@unina.it</email>.</corresp></author-notes><pub-date pub-type="epub"><day>13</day><month>02</month><year>2025</year></pub-date><pub-date pub-type="collection"><day>24</day><month>02</month><year>2025</year></pub-date><volume>64</volume><issue>7</issue><fpage>3335</fpage><lpage>3345</lpage><history><date date-type="received"><day>11</day><month>11</month><year>2024</year></date><date date-type="accepted"><day>06</day><month>02</month><year>2025</year></date><date date-type="rev-recd"><day>05</day><month>02</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; 2025 The Authors. Published by American Chemical Society</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>The Authors</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p content-type="toc-graphic"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ic4c04823_0009" id="ab-tgr1"/></p><p>Herein, the effects of a novel half-sandwich Os(II) complex
on
the aggregation of an amyloid model system, derived from the C-terminal
domain of the nucleophosmin 1 protein (NPM1<sub>264&#x02013;277</sub>), were investigated. The thioflavin T (ThT) binding assay revealed
that the complex [(&#x003b7;<sup>6</sup>-toluene)Os(NHCglu)Cl<sub>2</sub>] (where NHCglu is the N-heterocyclic carbene ligand 1-methyl-3-{2,3,4,6-tetra-<italic>O</italic>-acetyl-1-glucosyl}imidazol-2-ylidene), hence named <bold>Os-Tolu</bold>, was able to repress amyloid aggregation in a dose-dependent
way. Conformational studies through circular dichroism (CD) and Fourier
transform infrared (FTIR) spectroscopies clearly indicated that this
inhibitory effect occurred through the stabilization of &#x003b1;-helical
structures of monomeric NPM1<sub>264&#x02013;277</sub>, thus hampering
self-recognition. Electrospray ionization mass spectrometry (ESI-MS)
studies evidenced, through the formation of coordination adducts,
direct interactions of the amyloid peptide with the Os-glucoconjugate
complex that, in turn, promote chemical modifications of the sequence
further disfavoring the self-assembly process. Noticeably, the presence
of <bold>Os-Tolu</bold> completely repressed the formation of amyloid
fibers in scanning electron microscopy (SEM) analysis and induced
a slight rescue of cell viability, in contrast to its reduction caused
by the amyloid model in human SH-SY5Y neuroblastoma cells. These data
strongly support the hypothesis of expanding the use of osmium-based
agents to neurodegenerative diseases, positioning them as potential
neurodrugs.</p></abstract><abstract abstract-type="short"><p>The &#x003b7;<sup>6</sup>-arene Os(II)
NHC complex has demonstrated
effectiveness in inhibiting the amyloid aggregation of the NPM1<sub>264&#x02212;277</sub> peptide, assumed as an amyloid model. This complex
acts as an inhibitor of aggregation in the initial steps of the amyloid
process, effectively suppressing fiber formation and reducing amyloid
toxicity by recovering cell viability. These findings underscore its
potential application as a novel neurodrug.</p></abstract><funding-group><award-group><funding-source><institution-wrap><institution>NextGenerationEU</institution><institution-id institution-id-type="doi">10.13039/100031478</institution-id></institution-wrap></funding-source><award-id>NA</award-id></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution>Ministero dell''Universit&#x000c3;&#x000a0; e della Ricerca</institution><institution-id institution-id-type="doi">10.13039/501100021856</institution-id></institution-wrap></funding-source><award-id>PE0000006</award-id></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution>Associazione Italiana per la Ricerca sul Cancro</institution><institution-id institution-id-type="doi">10.13039/501100005010</institution-id></institution-wrap></funding-source><award-id>IG 2022 - 27378</award-id></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution>Ministero della Salute</institution><institution-id institution-id-type="doi">10.13039/501100003196</institution-id></institution-wrap></funding-source><award-id>NA</award-id></award-group></funding-group><custom-meta-group><custom-meta><meta-name>document-id-old-9</meta-name><meta-value>ic4c04823</meta-value></custom-meta><custom-meta><meta-name>document-id-new-14</meta-name><meta-value>ic4c04823</meta-value></custom-meta><custom-meta><meta-name>ccc-price</meta-name><meta-value/></custom-meta></custom-meta-group></article-meta></front><body><sec id="sec1"><title>Introduction</title><p>In the last decades, the use of transition-metal-based
drugs has
been extensively explored in medicinal chemistry,<sup><xref ref-type="bibr" rid="ref1">1</xref></sup> and currently, several efforts are being performed to design
metallodrugs with high efficacy, improved pharmacological properties,
and broad-spectrum activity.<sup><xref ref-type="bibr" rid="ref2">2</xref>&#x02212;<xref ref-type="bibr" rid="ref4">4</xref></sup> Metal-based drugs are valid tools
to fight amyloid diseases,<sup><xref ref-type="bibr" rid="ref5">5</xref>&#x02212;<xref ref-type="bibr" rid="ref8">8</xref></sup> a family of pathologies involving the formation of
toxic oligomers and fibrillar plaques in the brain through the aggregation
of amyloid protein/peptides.<sup><xref ref-type="bibr" rid="ref9">9</xref></sup> We<sup><xref ref-type="bibr" rid="ref10">10</xref>,<xref ref-type="bibr" rid="ref11">11</xref></sup> and others<sup><xref ref-type="bibr" rid="ref12">12</xref>&#x02212;<xref ref-type="bibr" rid="ref15">15</xref></sup> studied Pt(II), Ru(II),<sup><xref ref-type="bibr" rid="ref16">16</xref>&#x02212;<xref ref-type="bibr" rid="ref18">18</xref></sup> and Ru(III)<sup><xref ref-type="bibr" rid="ref19">19</xref>&#x02212;<xref ref-type="bibr" rid="ref23">23</xref></sup> complexes as amyloid inhibitors through a &#x0201c;drug
repurposing&#x0201d; approach concerning the employment of known anticancer
agents. Glucoconjugation is a promising strategy to improve the bioactivity
of organometallic complexes since the sugar moiety offers significant
advantages in terms of aqueous solubility and overall biocompatibility.<sup><xref ref-type="bibr" rid="ref24">24</xref>&#x02212;<xref ref-type="bibr" rid="ref26">26</xref></sup> Accordingly, we recently reported that glucoconjugated half-sandwich
Ru(II) complexes, of general formula [(&#x003b7;<sup>6</sup>-arene)Ru(NHC<sub>glu</sub>)Cl<sub>2</sub>], are valid inhibitors of amyloid aggregation.<sup><xref ref-type="bibr" rid="ref27">27</xref>,<xref ref-type="bibr" rid="ref28">28</xref></sup> Herein, the NHCglu ligand was chosen again but with another metal
ion, Os(II), to speculate different effects driven by the chemistry
of the metal in the complex.</p><p>Indeed, despite the structural
similarity to ruthenium compounds,
osmium complexes usually display greater kinetic inertness, easier
accessibility to higher oxidation states, and marked &#x003c0;-back-donation
properties in low oxidation states.<sup><xref ref-type="bibr" rid="ref29">29</xref></sup> In
recent years, they received ever-increasing attention in bioinorganic
chemistry.<sup><xref ref-type="bibr" rid="ref30">30</xref>&#x02212;<xref ref-type="bibr" rid="ref34">34</xref></sup></p><p>Half-sandwich Os(II) arene complexes have attracted much interest
for their chemical and biological properties.<sup><xref ref-type="bibr" rid="ref35">35</xref>&#x02212;<xref ref-type="bibr" rid="ref39">39</xref></sup> Noteworthily, the Sadler group observed that, in
aqueous systems, the hydrolysis of the Os&#x02013;Cl bond in Os(II)
complexes with formula [(&#x003b7;<sup>6</sup>-biphenyl)Os(en)Cl] (en
= ethylenediamine) was slower than that of the Ru(II) analogue, and
the resulting aqua-adduct was more acid.<sup><xref ref-type="bibr" rid="ref40">40</xref></sup> A comprehensive biological investigation on a derivative of formula
[Os(&#x003b7;<sup>6</sup>-<italic>p</italic>-cymene)(4-(2-pyridylazo)-<italic>N</italic>,<italic>N</italic>-dimethylaniline)I]PF<sub>6</sub> showed
high cytotoxicity toward many cancer cell lines and promising activity
in vivo, probably with a mechanism of action (MOA) different from
cisplatin.<sup><xref ref-type="bibr" rid="ref41">41</xref></sup> Later on, Os-based Noyori-type<sup><xref ref-type="bibr" rid="ref42">42</xref></sup> catalysts were found to be active for asymmetric
transfer hydrogenation inside cells.<sup><xref ref-type="bibr" rid="ref43">43</xref>,<xref ref-type="bibr" rid="ref44">44</xref></sup> Recently,
the Pizarro group demonstrated that the replacement of the chelating
N,N- or N,O- ligands with C,N-cyclometalated ligands (C,N = phenylpyridine)
in half-sandwich organoosmium(II) complexes produced highly basic
aqua-adducts with a cytotoxicity correlated to thioredoxin reductase
inhibition.<sup><xref ref-type="bibr" rid="ref45">45</xref></sup> The same group also reported
that the introduction of hemilabile tether alkoxy ligands in half-sandwich
Os(II) complexes is a valid strategy to tune the biological reactivity:
some of the complexes were able to catalyze the conversion of pyruvate
to lactate.<sup><xref ref-type="bibr" rid="ref46">46</xref></sup> Such a rich scenario can
inspire the development of half-sandwich osmium(II) organometallic
complexes in inorganic medicinal chemistry.</p><p>Based on these and
on our previous studies,<sup><xref ref-type="bibr" rid="ref27">27</xref>,<xref ref-type="bibr" rid="ref28">28</xref></sup> we investigated the
activity of a novel half-sandwich Os(II) complex
of formula [(&#x003b7;<sup>6</sup>-toluene)Os(NHC<sub>glu</sub>)Cl<sub>2</sub>] named <bold>Os-Tolu</bold> (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>).</p><fig id="fig1" position="float"><label>Figure 1</label><caption><p>(A) Structure of the Os(II) NHC complex <bold>Os-Tolu</bold>. (B)
Primary structure of NPM1<sub>264&#x02013;277</sub>.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ic4c04823_0001" id="gr1" position="float"/></fig><p>Amyloid-forming proteins and peptides are essential
tools in drug
discovery for neurodegenerative diseases, enabling the screening and
identification of modulators that target amyloid aggregation. Often,
peptides are used as structural models of amyloid even if they are
not directly linked to neurodegenerative conditions.<sup><xref ref-type="bibr" rid="ref47">47</xref>&#x02212;<xref ref-type="bibr" rid="ref49">49</xref></sup> In this context, a notable example is represented by a fragment
of nucleophosmin 1 (NPM1): although not a neurodegenerative protein,
it contains a well-characterized amyloidogenic region in the second
helix of its C-terminal domain, NPM1<sub>264&#x02013;277</sub>,<sup><xref ref-type="bibr" rid="ref50">50</xref></sup> which has been already used as an amyloid model.<sup><xref ref-type="bibr" rid="ref16">16</xref>,<xref ref-type="bibr" rid="ref28">28</xref>,<xref ref-type="bibr" rid="ref51">51</xref></sup></p><p>In this study, the <bold>Os-Tolu</bold> complex was synthesized
and fully characterized by spectroscopic techniques, and its activity
as an inhibitor of amyloid aggregation of NPM1<sub>264&#x02013;277</sub> was evaluated by several spectroscopic, biochemical, and biophysical
techniques, aiming for the development of osmium compounds as novel
antiamyloid therapeutics.</p></sec><sec id="sec2"><title>Results and Discussion</title><sec id="sec2.1"><title>Synthesis and Characterization of <bold>Os-Tolu</bold></title><p>In general, glycoconjugated metallodrugs<sup><xref ref-type="bibr" rid="ref52">52</xref>&#x02212;<xref ref-type="bibr" rid="ref56">56</xref></sup> display favorable properties including an enhancement
of intracellular accumulation through the Warburg Effect.<sup><xref ref-type="bibr" rid="ref57">57</xref></sup> NHC<sub>glu</sub> proved to be a highly versatile
ligand enabling the synthesis of glucoconjugated organometallic derivatives
of Pt,<sup><xref ref-type="bibr" rid="ref58">58</xref>&#x02212;<xref ref-type="bibr" rid="ref60">60</xref></sup> Au,<sup><xref ref-type="bibr" rid="ref61">61</xref>,<xref ref-type="bibr" rid="ref62">62</xref></sup> and Ru.<sup><xref ref-type="bibr" rid="ref63">63</xref></sup> Following a similar synthetic strategy, <bold>Os-Tolu</bold> was
obtained by a transmetalation reaction between the dimeric precursor
[Os(&#x003b7;<sup>6</sup>-tolueneCl<sub>2</sub>]<sub>2</sub> and 2 equiv
of the glucoconjugate silver carbene (Ag-NHC<sub>glu</sub>)<sup><xref ref-type="bibr" rid="ref58">58</xref></sup> in acetone. After removing the precipitated
AgBr, the compound was crystallized by the addition of diethyl ether
(<xref rid="sch1" ref-type="scheme">Scheme <xref rid="sch1" ref-type="scheme">1</xref></xref>).</p><fig id="sch1" position="float"><label>Scheme 1</label><caption><title>Synthetic
Route to Access <bold>Os-Tolu</bold></title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ic4c04823_0008" id="gr2" position="float"/></fig><p><bold>Os-Tolu</bold> was soluble in a wide range
of organic solvents
including acetone, DCM, chloroform, DMSO, methanol, and water (up
to ca. 50 mM). <sup>1</sup>H NMR spectra recorded in CDCl<sub>3</sub> and CD<sub>3</sub>OD display a broadening of signals at room temperature
(<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.inorgchem.4c04823/suppl_file/ic4c04823_si_001.pdf">Figures S1 and S2</ext-link>), which was resolved
by recording the spectra at 263 K (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>).</p><fig id="fig2" position="float"><label>Figure 2</label><caption><p><sup>1</sup>H NMR spectrum of <bold>Os-Tolu</bold> in CDCl<sub>3</sub> at 263 K. In the inset, the highlighted signals
are attributed
to the NHC imidazole (*) and the anomeric glucosyl (<bold>#</bold>) protons.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ic4c04823_0002" id="gr3" position="float"/></fig><p>At this temperature, the spectra show the presence
of two distinct
sets of signals attributable to two different species in a ratio 1:1.25.
These were identified as two rotamers probably in equilibrium through
the rotation around the Os&#x02013;C(NHC) bond and diastereomeric due
to the chirality of the sugar residue. A similar behavior was observed
for other chiral half-sandwich NHC complexes and in our analogue glucosylated
Ru(II)-NHC compounds.<sup><xref ref-type="bibr" rid="ref63">63</xref></sup> However, the two
species display similar spectral profiles, with the aromatic protons
of the &#x003c0;-bound toluene upfield shifted at 5&#x02013;6 ppm with
respect to free toluene, the sugar protons resonating at the expected
frequencies with the typical coupling constant (<sup>3</sup><italic>J)</italic> patterns of a <sup>4</sup>C<sub>1</sub> glucosyl ring
in &#x003b2;-configuration.<sup><xref ref-type="bibr" rid="ref64">64</xref></sup> The complex
was further characterized by recording <sup>1</sup>H&#x02013;<sup>1</sup>H COSY (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.inorgchem.4c04823/suppl_file/ic4c04823_si_001.pdf">Figure S3</ext-link>) and <sup>13</sup>C
(<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.inorgchem.4c04823/suppl_file/ic4c04823_si_001.pdf">Figure S4</ext-link>) NMR spectra at 263 K in CDCl<sub>3</sub>. The carbene carbon atoms resonated at 162 and 164 ppm, in
line with the chemical shift observed for other &#x003b7;<sup>6</sup>-arene Os(II) complexes.<sup><xref ref-type="bibr" rid="ref65">65</xref>,<xref ref-type="bibr" rid="ref66">66</xref></sup> The hydrolytic behavior
of the complex in aqueous systems was assessed by UV&#x02013;vis spectroscopy
and ESI-MS. The UV&#x02013;vis spectra of <bold>Os-Tolu</bold> in water
over 5 h (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.inorgchem.4c04823/suppl_file/ic4c04823_si_001.pdf">Figure S5A</ext-link>) revealed a substantial
lack of variation of bands, confirming the stability of the complex
in the investigated interval time. ESI-MS (see <xref rid="sec4.1" ref-type="other">Materials and Methods</xref> for details) suggested the hydrolysis
of the Os-Cl coordination to form reactive aqua-adducts.<sup><xref ref-type="bibr" rid="ref63">63</xref></sup></p></sec><sec id="sec2.2"><title>Fluorescence Studies: Thioflavin T (ThT) and Autofluorescence</title><p>To analyze the effects of the <bold>Os-Tolu</bold> complex on the
amyloid aggregation of NPM1<sub>264&#x02013;277</sub>, the thioflavin
T (ThT) assay was employed. The overlays of fluorescence emission
profiles in the presence or absence of the <bold>Os-Tolu</bold> complex
are reported in <xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>A.</p><fig id="fig3" position="float"><label>Figure 3</label><caption><p>Left panel: (A) ThT fluorescence assay of NPM1<sub>264&#x02013;277</sub> alone (black) and NPM1<sub>264&#x02013;277</sub> in the presence
of <bold>Os-Tolu</bold> 1:1 (blue) and 1:5 (green). <bold>Os-Tolu</bold> alone is reported in red. Right panel: overlay of florescence emission
spectra: &#x003bb;<sub>exc</sub>= 440 nm of (B) NPM1<sub>264&#x02013;277</sub> alone and (C) NPM1<sub>264&#x02013;277</sub> in the presence of <bold>Os-Tolu</bold> 1:5.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ic4c04823_0003" id="gr4" position="float"/></fig><p>The NMP1<sub>264&#x02013;277</sub> peptide at <italic>t</italic> = 0 displayed a no zero value, which indicated an already
aggregated
state despite HFIP treatment (see <xref rid="sec4.1" ref-type="other">Materials and
Methods</xref>).</p><p>The presence of the complex caused a neat decrease
of the ThT signal
at early stages of aggregation in a dose-dependent way: the equimolar
condition (1:1 ratio) caused an inhibition of &#x0223c;60%, while the
1:5 ratio resulted in a major suppressive effect with a reduction
in signal of &#x0223c;80%. The autofluorescence assay for amyloid systems
is emerging as a crucial method for assessing the modulatory impact
of external agents on amyloid aggregation.<sup><xref ref-type="bibr" rid="ref67">67</xref></sup> The effect of the <bold>Os-Tolu</bold> complex on the autofluorescence
of NPM1<sub>264&#x02013;277</sub> was assessed by recording fluorescence
emission spectra over time with excitation at 440 nm (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>B). In these conditions, NPM1<sub>264&#x02013;277</sub> alone displayed two emission maxima at 478 and
525 nm, as previously reported.<sup><xref ref-type="bibr" rid="ref51">51</xref></sup> Afterward,
a slight increase in signal after 2 h of aggregation was followed
by a decrease in intensity up to 4 h. In the presence of the <bold>Os-Tolu</bold> complex, a drastic reduction of blue fluorescence
was observed. As a control experiment, the Os complex alone showed
a signal not comparable to that exhibited by NPM1 <sub>264&#x02013;277</sub> alone and quite similar to that in the presence of the amyloid peptide
(<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.inorgchem.4c04823/suppl_file/ic4c04823_si_001.pdf">Figure S5B</ext-link>).</p></sec><sec id="sec2.3"><title>Conformational Studies: CD and FTIR Spectroscopy</title><p>To
assess whether the presence of the <bold>Os-Tolu</bold> complex could
influence the conformational features of the NPM1<sub>264&#x02013;277</sub> peptide, CD spectra of the peptide alone and in the presence of
the Os complex were recorded at different times. The overlays of the
spectra are reported in the upper panel of <xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>.</p><fig id="fig4" position="float"><label>Figure 4</label><caption><p>Upper panel: overlay of CD spectra over time
of (A) NPM1<sub>264&#x02013;277</sub> and (B) NPM1<sub>264&#x02013;277</sub> + <bold>Os-Tolu</bold> 1:1
molar ratio. Lower panel: FTIR spectra of (C) NPM1<sub>264&#x02013;277</sub> alone and in the presence of <bold>Os-Tolu</bold> 1:1 molar ratio
and (D) deconvoluted and second-derivative FTIR spectra.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ic4c04823_0004" id="gr5" position="float"/></fig><p>CD profiles already exhibited distinct features
between the peptide
alone (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>A) and
in the presence of the <bold>Os-Tolu</bold> complex (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>B) at <italic>t</italic> =
0. As already reported,<sup><xref ref-type="bibr" rid="ref50">50</xref></sup> NPM1 <sub>264&#x02013;277</sub> exhibited CD spectra with a broad band centered at &#x0223c;218 nm,
suggesting mixed &#x003b1; + &#x003b2; conformations, where the Cotton
effect slightly decreased during the time for aggregation.<sup><xref ref-type="bibr" rid="ref50">50</xref></sup> The presence of the <bold>Os-Tolu</bold> complex
determined the onset of a maximum at 190 nm and two minima at 208
and 220 nm, respectively, that are typical of &#x003b1;-helix conformation,
which is the native conformation of this sequence in the protein architecture.<sup><xref ref-type="bibr" rid="ref68">68</xref></sup> These considerations were confirmed by the deconvolution
data reported in <xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref> showing a clear stabilization of the &#x003b1;-helix structure at
early stages in the presence of the <bold>Os-Tolu</bold> complex.
As control CD signal of the complex alone, reported in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.inorgchem.4c04823/suppl_file/ic4c04823_si_001.pdf">Figure S6A</ext-link>, indicated a negligible CD signal.</p><table-wrap id="tbl1" position="float"><label>Table 1</label><caption><title>Deconvolution of CD Spectra of NPM1<sub>264-277</sub> Alone and in the Presence of <bold>Os-Tolu</bold> at a 1:1 Molar Ratio Reported in <xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>A,B at the Indicated Times</title></caption><table frame="hsides" rules="groups" border="0"><colgroup><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/></colgroup><thead><tr><th style="border:none;" align="center">&#x000a0;</th><th style="border:none;" align="center"><bold>time (h)</bold></th><th style="border:none;" align="center">&#x003b1;-helix</th><th style="border:none;" align="center">&#x003b2;-sheet</th><th style="border:none;" align="center"><bold>turn</bold></th><th style="border:none;" align="center"><bold>others</bold></th></tr></thead><tbody><tr><td rowspan="4" style="border:none;" align="left">NPM1<sub>264&#x02013;277</sub></td><td style="border:none;" align="left">0</td><td style="border:none;" align="left">34.7</td><td style="border:none;" align="left">20.7</td><td style="border:none;" align="left">8.0</td><td style="border:none;" align="left">36.6</td></tr><tr><td style="border:none;" align="left">0.5</td><td style="border:none;" align="left">29.3</td><td style="border:none;" align="left">25</td><td style="border:none;" align="left">9.4</td><td style="border:none;" align="left">36.3</td></tr><tr><td style="border:none;" align="left">1.5</td><td style="border:none;" align="left">21.5</td><td style="border:none;" align="left">24.3</td><td style="border:none;" align="left">10.8</td><td style="border:none;" align="left">43.4</td></tr><tr><td style="border:none;" align="left">2.5</td><td style="border:none;" align="left">28.3</td><td style="border:none;" align="left">26.5</td><td style="border:none;" align="left">9.3</td><td style="border:none;" align="left">35.9</td></tr><tr><td rowspan="4" style="border:none;" align="left">NPM1<sub>264&#x02013;277</sub> +<bold>Os-Tolu</bold></td><td style="border:none;" align="left">0</td><td style="border:none;" align="left">41.9</td><td style="border:none;" align="left">10.7</td><td style="border:none;" align="left">4.6</td><td style="border:none;" align="left">42.8</td></tr><tr><td style="border:none;" align="left">0.5</td><td style="border:none;" align="left">36.8</td><td style="border:none;" align="left">7.4</td><td style="border:none;" align="left">7.6</td><td style="border:none;" align="left">48.1</td></tr><tr><td style="border:none;" align="left">1.5</td><td style="border:none;" align="left">28.5</td><td style="border:none;" align="left">9.9</td><td style="border:none;" align="left">10.7</td><td style="border:none;" align="left">50.8</td></tr><tr><td style="border:none;" align="left">2.5</td><td style="border:none;" align="left">19.8</td><td style="border:none;" align="left">11.5</td><td style="border:none;" align="left">11.8</td><td style="border:none;" align="left">56.9</td></tr></tbody></table></table-wrap><p>FTIR spectroscopy confirmed the &#x003b1;-helical stabilization
effect
of the <bold>Os-Tolu</bold> complex (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>, lower panel). The IR spectra of NPM1<sub>264&#x02013;277</sub> alone and in the presence of the <bold>Os-Tolu</bold> complex were analyzed after 2 h of stirring. NPM1 <sub>264&#x02013;277</sub> alone contained &#x003b2;-sheets with the presence of a dominant peak
at &#x0223c;1630 cm<sup>&#x02013;1</sup> and a second shoulder at 1680
cm<sup>&#x02013;1</sup> (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>C), indicating an antiparallel orientation of the &#x003b2;-strands.<sup><xref ref-type="bibr" rid="ref69">69</xref></sup> The analysis of second derivative spectra (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>D) allowed the deepening
of secondary structures,<sup><xref ref-type="bibr" rid="ref70">70</xref></sup> and deconvoluted
data (<xref rid="tbl2" ref-type="other">Table <xref rid="tbl2" ref-type="other">2</xref></xref>) indicated
that NPM1<sub>264&#x02013;277</sub> alone contained &#x003b2;-sheet structures,
while the presence of the <bold>Os-Tolu</bold> complex promoted a
conformational stabilization of the &#x003b1;-helix conformation. This
is evidenced by the characteristic &#x003b1;-helix band at 1656 cm<sup>&#x02013;1</sup> corresponding to hydrogen-bonded C=O stretches
in the &#x003b1;-helix conformation.</p><table-wrap id="tbl2" position="float"><label>Table 2</label><caption><title>Deconvoluted Amide I Band Frequencies
and Assignments to the Secondary Structure for NPM1<sub>264-277</sub> Alone and in the Presence of <bold>Os-Tolu</bold> at a 1:1 Molar
Ratio</title></caption><table frame="hsides" rules="groups" border="0"><colgroup><col align="left"/><col align="left"/><col align="left"/></colgroup><thead><tr><th style="border:none;" align="center">&#x000a0;</th><th style="border:none;" align="center"><bold>mean frequencies</bold></th><th style="border:none;" align="center"><bold>assignment</bold></th></tr></thead><tbody><tr><td style="border:none;" align="left">NPM1<sub>264&#x02013;277</sub></td><td style="border:none;" align="left">1642&#x000a0;&#x000b1;&#x000a0;1.0</td><td style="border:none;" align="left">&#x003b2;-sheet</td></tr><tr><td style="border:none;" align="left">NPM1<sub>264&#x02013;277</sub> + <bold>Os-Tolu</bold> complex</td><td style="border:none;" align="left">1656 &#x000b1; 2.0</td><td style="border:none;" align="left">&#x003b1;-helix</td></tr></tbody></table></table-wrap></sec><sec id="sec2.4"><title>ESI-MS Analysis of the Adducts between <bold>Os-Tolu</bold> and
NPM1<sub>264&#x02013;277</sub></title><p>We analyzed the formation of
potential adducts between the <bold>Os-Tolu</bold> complex and NPM1<sub>264&#x02013;277</sub> peptide through electrospray ionization mass
spectrometry (ESI-MS): mass spectra were registered after 2 h of stirring
and are reported in <xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>. The complex alone was analyzed as the control, and the related
spectrum is reported in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.inorgchem.4c04823/suppl_file/ic4c04823_si_001.pdf">Figure S6B</ext-link>.</p><fig id="fig5" position="float"><label>Figure 5</label><caption><p>ESI-MS spectra
of (A) NPM1<sub>264&#x02013;277</sub> + <bold>Os-Tolu</bold> 1:1 molar
ratio and of (B) NPM1<sub>264&#x02013;277</sub> alone reported
as reference. Asterisks (*) highlight the species present in the complex
alone.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ic4c04823_0005" id="gr6" position="float"/></fig><p>In the presence of <bold>Os-Tolu</bold>, many additional
peaks
were evident due to the formation of adducts between the complex and
the peptide with a 1:1 stoichiometry (<xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref> and <xref rid="tbl3" ref-type="other">Table <xref rid="tbl3" ref-type="other">3</xref></xref>). Specifically, peak #1 (<italic>m</italic>/<italic>z</italic> = 1251.6 and 834.32 a.m.u.) was due to the formation of
an adduct peptide/metal complex with the loss of one chloride ligand,
peak #2 (<italic>m</italic>/<italic>z =</italic> 1233.66 and 822.72
a.m.u.) was from the same adduct with the loss of the second chloride
ligand, and peak #3 (<italic>m</italic>/<italic>z</italic> = 1212.66
and 806.22 a.m.u.) was from the same product with the additional loss
of one acetyl group of the sugar moiety. In the identification of
different species, several peaks are consistent with dual Cys <sup>275</sup> oxidation as already reported,<sup><xref ref-type="bibr" rid="ref51">51</xref></sup> with the occurrence of signals at <italic>m</italic>/<italic>z</italic> 902.46 and 910.79 a.m.u. (<xref rid="tbl3" ref-type="other">Table <xref rid="tbl3" ref-type="other">3</xref></xref>) corresponding to the dioxidated form of Cys as sulfinic
acid<sup><xref ref-type="bibr" rid="ref71">71</xref></sup> (2ox NPM1<sub>264&#x02013;277</sub>) and to the trioxidized form of Cys as sulfonic acid<sup><xref ref-type="bibr" rid="ref72">72</xref></sup> (3ox NPM1<sub>264&#x02013;277</sub>).</p><table-wrap id="tbl3" position="float"><label>Table 3</label><caption><title>Table of the Main Observed MS Peaks
Formed by NPM1<sub>264&#x02013;277</sub> in the Absence and in the
Presence of the <bold>Os-Tolu</bold> Complex after 2 h of Stirring</title></caption><table frame="hsides" rules="groups" border="0"><colgroup><col align="left"/><col align="left"/><col align="left"/></colgroup><thead><tr><th style="border:none;" align="center"><bold>description</bold></th><th style="border:none;" align="center"><italic>m</italic>/<italic>z</italic><bold>(charge)</bold></th><th style="border:none;" align="center"><bold>theoretical</bold><italic>m</italic>/<italic>z</italic></th></tr></thead><tbody><tr><td style="border:none;" align="left">NPM1<sub>264&#x02013;277</sub></td><td style="border:none;" align="left">1772.42</td><td style="border:none;" align="left">1772.08</td></tr><tr><td style="border:none;" align="left">NPM1<sub>264&#x02013;277</sub></td><td style="border:none;" align="left">886.84&#x000a0;(+2)</td><td style="border:none;" align="left">887</td></tr><tr><td style="border:none;" align="left">NPM1<sub>264&#x02013;277</sub></td><td style="border:none;" align="left">591.75&#x000a0;(+3)</td><td style="border:none;" align="left">591.66</td></tr><tr><td style="border:none;" align="left">2ox NPM1<sub>264&#x02013;277</sub></td><td style="border:none;" align="left">902.46&#x000a0;(+2)</td><td style="border:none;" align="left">902.48</td></tr><tr><td style="border:none;" align="left">3ox NPM1<sub>264&#x02013;277</sub></td><td style="border:none;" align="left">910.79&#x000a0;(+2)</td><td style="border:none;" align="left">910.48</td></tr><tr><td style="border:none;" align="left">NPM1<sub>264&#x02013;277</sub> + <bold>Os-Tolu</bold>-1Cl (#1)</td><td style="border:none;" align="left">1251.6&#x000a0;(+2)</td><td style="border:none;" align="left">1251.5</td></tr><tr><td style="border:none;" align="left">NPM1<sub>264&#x02013;277</sub> + <bold>Os-Tolu</bold>-1Cl (#1)</td><td style="border:none;" align="left">834.32&#x000a0;(+3)</td><td style="border:none;" align="left">834.66</td></tr><tr><td style="border:none;" align="left">NPM1<sub>264&#x02013;277</sub> + <bold>Os-Tolu</bold>-2Cl (#2)</td><td style="border:none;" align="left">1233.66&#x000a0;(+2)</td><td style="border:none;" align="left">1234.00</td></tr><tr><td style="border:none;" align="left">NPM1<sub>264&#x02013;277</sub> + <bold>Os-Tolu</bold>-2Cl (#2)</td><td style="border:none;" align="left">822.72&#x000a0;(+3)</td><td style="border:none;" align="left">823.00</td></tr><tr><td style="border:none;" align="left">NPM1<sub>264&#x02013;277</sub> + <bold>Os-Tolu</bold>-2Cl- 1Ac
(#3)</td><td style="border:none;" align="left">1212.66&#x000a0;(+2)</td><td style="border:none;" align="left">1212.04</td></tr><tr><td style="border:none;" align="left">NPM1<sub>264&#x02013;277</sub> + <bold>Os-Tolu</bold>-2Cl- 1Ac
(#3)</td><td style="border:none;" align="left">806.22&#x000a0;(+3)</td><td style="border:none;" align="left">808.69</td></tr></tbody></table></table-wrap><p>To corroborate our assignment, we compared the experimental
and
simulated isotopic pattern of several <italic>m</italic>/<italic>z</italic> values (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.inorgchem.4c04823/suppl_file/ic4c04823_si_001.pdf">Figure S7 and Table S1</ext-link>), with
good agreement.</p></sec><sec id="sec2.5"><title>Effects of <bold>Os-Tolu</bold> on the Morphologies of NPM1<sub>264&#x02013;277</sub> Derived Fibers</title><p>To get insights into
potential variations of the morphology of the aggregates derived from
the NPM1<sub>264&#x02013;277</sub> peptide in the presence and in the
absence of <bold>Os-Tolu</bold>, scanning electron microscopy (SEM)
analysis was used. The samples were analyzed after 4 h of aggregation,
and the resulting micrographs are shown in <xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref>. As can be noticed, while the peptide alone
produced a well-defined fiber,<sup><xref ref-type="bibr" rid="ref73">73</xref></sup> the presence
of the <bold>Os-Tolu</bold> complex significantly affects the formation
of the amyloid fibers, leading to their total suppression (<xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref> B,B&#x02032;). As
a control, under the same experimental conditions, the SEM of the
complex alone, reported in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.inorgchem.4c04823/suppl_file/ic4c04823_si_001.pdf">Figure S6C</ext-link>,
did not highlight the presence of any aggregate.</p><fig id="fig6" position="float"><label>Figure 6</label><caption><p>SEM micrographs of NPM1<sub>264&#x02013;277</sub> (100 &#x003bc;M)
alone (A, A&#x02032;) and in the presence of <bold>Os-Tolu</bold> (B,
B&#x02032;) at 1:1 peptide/metal complex molar ratio. Overviews of
the surface of the samples at 300 &#x003bc;m (A, B) and 30 &#x003bc;m
(A&#x02032;, B&#x02032;).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ic4c04823_0006" id="gr7" position="float"/></fig></sec><sec id="sec2.6"><title>Cellular Effects of <bold>Os-Tolu</bold> on the Amyloid Cytotoxicity
of NPM1<sub>264&#x02013;277</sub></title><p>To determine whether <bold>Os-Tolu</bold> can protect against amyloid-induced cytotoxicity,
we conducted an MTT assay on SH-SY5Y cells at two time points: 0 and
2 h of aggregation. SH-SY5Y cells were treated with the peptide NPM1<sub>264&#x02013;277</sub> alone and with the peptide NPM1<sub>264&#x02013;277</sub> in the presence of the <bold>Os-Tolu</bold> complex in a 1:1 molar
ratio. The histogram of cell viability is reported in <xref rid="fig7" ref-type="fig">Figure <xref rid="fig7" ref-type="fig">7</xref></xref>. As already observed, NPM1<sub>264&#x02013;277</sub> reduced cell viability by approximately 20%
after 2 h of aggregation; in contrast, the presence of the <bold>Os-Tolu</bold> complex showed a trend toward a recovery of cell viability at the
same time. The <bold>Os-Tolu</bold> complex alone displayed a level
of cytotoxicity comparable to that of the peptide NPM1<sub>264&#x02013;277</sub> after 2 h of aggregation, although these variations were not significant.</p><fig id="fig7" position="float"><label>Figure 7</label><caption><p>Effects
of <bold>Os-Tolu</bold> on the cytotoxicity of the NPM1 <sub>264&#x02013;277</sub> peptide in SH-SY5Y neuroblastoma cells: the
MTT assay of NPM1 <sub>264&#x02013;277</sub> peptide in the absence
and in the presence of <bold>Os-Tolu</bold>, incubated under stirring,
at <italic>t</italic> = 0 and 2 h. Control refers to untreated cells
as 100% of viable cells. Data are reported as mean &#x000b1; standard
deviation. Statistical comparisons were performed with a Student&#x02019;s
unpaired <italic>t</italic>-test.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ic4c04823_0007" id="gr8" position="float"/></fig></sec></sec><sec id="sec3"><title>Conclusions</title><p>A substantial number of osmium complexes,
featuring the metal in
various oxidation states (II, III, IV, VI),<sup><xref ref-type="bibr" rid="ref30">30</xref>,<xref ref-type="bibr" rid="ref32">32</xref>,<xref ref-type="bibr" rid="ref34">34</xref>,<xref ref-type="bibr" rid="ref35">35</xref>,<xref ref-type="bibr" rid="ref74">74</xref></sup> displayed notable antiproliferative activity against
cancer cell lines. Organoosmium(II) arene compounds show a wide range
of biological activities in which the charge and the steric hindrance
of ligands exert a primary role in substitution-hydrolysis processes,
and osmium reactivity can be finely tuned by selecting appropriate
chelating ligands.<sup><xref ref-type="bibr" rid="ref75">75</xref>,<xref ref-type="bibr" rid="ref46">46</xref>,<xref ref-type="bibr" rid="ref76">76</xref></sup> In the present study, an Os(II) complex with a &#x003b7;<sup>6</sup>-toluene, a glucoconjugated NHC, and two chlorides as ligands, named <bold>Os-Tolu</bold> (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>), was investigated for its ability to interfere with the aggregation,
fibrillation, and cytotoxicity of the amyloid model corresponding
to the fragment NPM1<sub>264&#x02013;277.</sub></p><p>By the ThT assay,
we evaluated the ability of <bold>Os-Tolu</bold> to almost abolish
the formation of amyloid aggregates even at a
1:1 molar ratio. This inhibition translated into a complete suppression
of amyloid fibers in the presence of the metal complex, as detected
by SEM analysis, and provided a tendency to rescue cellular viability
in SH-SY5Y cells. ESI-MS investigations suggested the formation of
coordination adducts with the loss of chlorides around the metal ion.
Additionally, it should also be underlined that the redox activity
of the complex can exert a primary role in its MOA: our data clearly
indicate that, in the case of the amyloid sequence containing cysteines,
as NPM1 <sub>264&#x02013;277</sub>, this complex can promote, stoichiometrically
or catalytically, the progressive oxidation of thiols as already reported
for similar complexes.<sup><xref ref-type="bibr" rid="ref37">37</xref>,<xref ref-type="bibr" rid="ref77">77</xref></sup> The presence of sulfoxide and
sulphone species can create a more hydrophilic environment<sup><xref ref-type="bibr" rid="ref23">23</xref>,<xref ref-type="bibr" rid="ref78">78</xref></sup> that limits the self-recognition mechanism among monomers that is
the basis of the aggregation process. This result can explain the
stabilization of an &#x003b1;-helical conformation of the NPM1<sub>264&#x02013;277</sub> monomer. The &#x003b1;-helix is the native conformation of the sequence
264&#x02013;277 in NMP1,<sup><xref ref-type="bibr" rid="ref68">68</xref></sup> and this is one
of the few examples of a metallodrug that inhibits the amyloid aggregation
of NPM1<sub>264&#x02013;277</sub> by fixing its helical conformation,
as assessed through both CD and FTIR spectroscopies. This evidence
also confirms our speculation concerning the fact that the &#x003b1;-helix
is &#x0201c;a protective&#x0201d; conformation adopted by the NPM1 C-terminal
domain to avoid the aggregation<sup><xref ref-type="bibr" rid="ref50">50</xref></sup> of the
wild-type protein that instead occurs in AML mutated versions of this
protein.<sup><xref ref-type="bibr" rid="ref79">79</xref>&#x02212;<xref ref-type="bibr" rid="ref82">82</xref></sup> Indeed, recently, we performed an analogue study employing Ru-based
complexes quite similar to the Os compound analyzed in the present
investigation:<sup><xref ref-type="bibr" rid="ref28">28</xref></sup> data indicated similar
ThT signal reductions and the formation of a coordination adduct between
NPM1 <sub>264&#x02013;277</sub> and the metal complex with the release
of the same ligands. In addition, in the case of the Os(II) complex,
a more pronounced helical content with respect to that containing
Ru(II) ion was observed.</p><p>The neat positive charge of the aqua-species
derived from Os-Cl
hydrolysis in <bold>Os-Tolu</bold> favored its interaction with a
peptide sequence with a high pI value, &#x0223c;10, such as NPM1<sub>264&#x02013;277</sub>.<sup><xref ref-type="bibr" rid="ref50">50</xref></sup> The present investigation
is, to the best of our knowledge, only the second example of the employment
of the Os(II) complex present in the literature.<sup><xref ref-type="bibr" rid="ref83">83</xref></sup> Indeed, in a concomitant study, a piano-stool osmium complex
revealed the ability to inhibit A&#x003b2; aggregation even with different
MOAs. In this case, the complex presents a different structure, i.e.,
[(&#x003b7;<sup>6</sup>-<italic>p</italic>-cymene)Os<bold>L</bold>Cl]PF<sub>6</sub>, where L is a bidentate chelating quinoline benzimidazole-based
ligand. ESI-MS did not provide indications on the formation of any
coordination adduct between the Os complex and the peptide upon ligand
substitutions around the metal ion. In that case, the Os complex did
not completely abolish the formation of amyloid fibers, and the required
presence of DMSO (at 5% (v/v)), likely due to the lack of hydrophilic
ligands as glucosyl,<sup><xref ref-type="bibr" rid="ref84">84</xref></sup> could limit its
translation as a neurodrug, confirming that the design of the coordination
environment of metallodrugs has a crucial impact on the chemical properties
and the biological effects in medicinal inorganic chemistry.</p><p>In preliminary investigations, <bold>Os-Tolu</bold> was revealed
to be able to suppress the aggregation of A&#x003b2;<sub>1&#x02013;42</sub>, but further ongoing studies are required to deepen differences
in the MOAs of <bold>Os-Tolu</bold> toward diverse amyloid systems.
In conclusion, this study highlights the potentialities of Os-based
metallodrugs in the field of amyloid aggregation and can pave the
way to their different employment in innovative neurodiagnostic and
neurotherapeutic strategies.</p></sec><sec id="sec4"><title>Experimental Section</title><sec id="sec4.1"><title>Materials and Methods</title><p>Reagents and solvents were used
as received from commercial suppliers. [Os(&#x003b7;<sup>6</sup>-tolueneCl<sub>2</sub>]<sub>2</sub> and Ag-NHC<sub>glu</sub><sup><xref ref-type="bibr" rid="ref58">58</xref></sup> were prepared according to literature procedures. NMR spectra
were acquired on a Bruker Avance NEO 600 MHz NMR spectrometer equipped
with a cryogenically cooled proton-optimized TCI probe. The solvents
for NMR studies were CDCl<sub>3</sub> (CHCl3, &#x003b4; 7.26, and <sup>13</sup>CDCl3, &#x003b4; 77.0, as internal standards) and CD<sub>3</sub>OD (CD<sub>2</sub>HOD, &#x003b4; 3.30, and 13CD<sub>3</sub>OD, &#x003b4;
49.0, as internal standards). The following abbreviations were used
to describe NMR multiplicity: s, singlet; d, doublet; dd, double doublet;
triplet; and m, multiplet.</p></sec><sec id="sec4.2"><title>Synthesis of the <bold>Os-Tolu</bold> Complex</title><p>[Os(&#x003b7;<sup>6</sup>-tolueneCl<sub>2</sub>]<sub>2</sub> (100 mg, 0.14 mmol) and
Ag-NHC<sub>glu</sub> (183 mg, 0.30 mmol) were stirred protected from
light in acetone (10 mL) for 18 h. At the end of this time, the precipitated
AgBr was filtered off through a pad of Celite, and the clear filtrate
was reduced in volume to ca. 2 mL. Addition of diethyl ether resulted
in the precipitation of a yellowish solid, which was washed with ether
and dried under a vacuum. Yield: 68%.</p><p><sup>1</sup>H NMR (600
MHz, CDCl<sub>3</sub>) &#x003b4; 7.25 (d, <italic>J</italic> = 2.3 Hz,
1H, H-Im), 7.15 (d, <italic>J</italic> = 2.2 Hz, 1H, H-Im), 6.94 (d, <italic>J</italic> = 2.1 Hz, 1H, H-Im), 6.90 (d, <italic>J</italic> = 2.2
Hz, 1H, H-Im), 6.78 (d, <italic>J</italic> = 9.5 Hz, 1H, H1-glu),
6.27 (d, <italic>J</italic> = 9.9 Hz, 1H, H1-glu), 5.81 (t, <italic>J</italic> = 5.2 Hz, 1H, H-glu), 5.70 (t, <italic>J</italic> = 5.2
Hz, 1H, H-glu), 5.66 (t, <italic>J</italic> = 5.2 Hz, 1H, H-glu),
5.62 (t, <italic>J</italic> = 5.1 Hz, 1H, H-glu), 5.60&#x02013;5.51
(m, 7H), 5.45 (td, <italic>J</italic> = 9.4, 6.2 Hz, 2H), 5.24 (t, <italic>J</italic> = 9.2 Hz, 1H), 5.20 (t, <italic>J</italic> = 9.7 Hz, 1H),
5.07 (t, <italic>J</italic> = 7.7 Hz, 1H), 4.25 (dd, <italic>J</italic> = 12.7, 4.6 Hz, 1H, H-glu), 4.17 (dd, <italic>J</italic> = 12.4,
2.0 Hz, 1H, H-glu), 4.14&#x02013;4.09 (m, 2H, H-glu), 4.08&#x02013;4.01
(m, 1H, H-glu), 4.00 (s, 3H, Me-Im), 3.99 (s, 3H, Me-Im), 3.91 (ddd, <italic>J</italic> = 9.7, 7.4, 2.0 Hz, 1H), 2.33 (s (x2), 6H, Me-Tol), 2.07
(s (x2), 6H, OAc), 2.05 (s, 3H, OAc), 2.04 (s (x2), 6H, OAc), 2.02
(s, 3H, OAc), 2.01 (s, 3H, OAc), 1.97 (s, 3H, OAc). <sup>13</sup>C
NMR (176 MHz, CDCl3) &#x003b4; 171.20, 170.61, 170.43 (x2), 169.87 (x2),
169.85, 168.64, 164.13, 162.01, 123.91, 123.26, 119.26, 118.66, 99.27,
98.59, 85.58, 85.41, 79.75, 79.60, 78.74, 78.04, 76.48, 76.44, 76.27,
76.00, 74.05, 73.92, 73.89, 73.10, 70.52, 68.64, 68.57, 68.54, 67.85,
67.68, 63.06, 61.37, 39.93, 39.65, 21.25, 21.12(x2), 21.03, 20.85
(x2), 20.83, 20.72, 18.86, 18.74. ESI-MS(+, MeOH), <italic>m</italic>/<italic>z</italic>: 653.21 [M &#x02013; 2Cl-OAc], 731.22 [M &#x02013;
Cl]<sup>+</sup></p></sec><sec id="sec4.3"><title>Peptide Synthesis</title><p>The NPM1<sub>264&#x02013;277</sub> peptide was synthesized as already reported<sup><xref ref-type="bibr" rid="ref50">50</xref></sup> and after purification was treated with 1,1,1,3,3,3-hexafluoro-2-propanol
(HFIP) and stored at &#x02212;20 &#x000b0;C until use.</p></sec><sec id="sec4.4"><title>Fluorescence Assays</title><p>The ThT emission assay was carried
out in black plates (96 wells) under stirring on the fluorescence
reader Envision 2105 (PerkinElmer) at 25 &#x000b0;C using a ThT concentration
of 50 &#x003bc;M and 20 mM borate buffer (pH = 8.5). The peptide was
assayed at a concentration of 200 &#x003bc;M alone and in the presence
of the <bold>Os- Tolu</bold> complex (stock solution, 50 mM in H<sub>2</sub>O) at 1:1 and 1:5 peptide/metal complex molar ratios. The
autofluorescence (&#x003bb;<sub>ex</sub> = 440 nm) assay was performed
on a Jasco FP 8300 spectrofluorometer at a peptide concentration of
200 &#x003bc;M at 25 &#x000b0;C in 50 mM borate buffer alone and in the
presence of the complex. Spectra were registered at indicated times,
after stirring, with a scanning speed 50 nm/min.</p></sec><sec id="sec4.5"><title>Circular Dichroism</title><p>CD spectra of NPM1<sub>264&#x02013;277</sub> were registered in the far-UV region from 190 to 260 nm on a J-810
spectropolarimeter (JASCO Corp., Milan, Italy) at a concentration
of 100 &#x003bc;M in 20 mM borate buffer pH 8.5, alone and in the presence
of the <bold>Os-Tolu</bold> complex at a 1:1 peptide to metal complex
molar ratio. Spectra of NPM1<sub>264&#x02013;277</sub> + <bold>Os-Tolu</bold> were subtracted from the spectrum of <bold>Os-Tolu</bold> alone.
A 0.1 cm cuvette at 25 &#x000b0;C was used with the following: scan speed
= 20 nm/min, bandwidth= 2.0 nm, resolution = 0.2 nm, sensitivity =
50 mdeg, and response = 4 s. Deconvolution was obtained by employing
the BESTSEL software (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://bestsel.elte.hu/">http://bestsel.elte.hu/</uri>).<sup><xref ref-type="bibr" rid="ref85">85</xref></sup></p></sec><sec id="sec4.6"><title>FTIR Spectroscopy</title><p>Fourier transform infrared spectra
of NPM1<sub>264&#x02013;277</sub> alone (300 &#x003bc;M) and in the presence
of the <bold>Os-Tolu</bold> complex at a 1:1 molar ratio were registered
in 50 mM borate buffer at pH 8.5 on a Jasco FT/IR 4100 spectrometer
(Easton, MD, USA) in an attenuated total reflection (ATR) mode. The
measurements were performed with a Ge single crystal at a resolution
of 4 cm<sup>&#x02013;1</sup> after 1.5 h of stirring and subsequent
drying under a vacuum. A total of 100 scans were recorded for each
sample at a rate of 2 mm&#x000b7;s<sup>&#x02013;1</sup> against a KBr
background. After the collection in transmission mode, the spectra
were converted to emission. Amide I deconvolutions were automatically
returned as emissions with the built-in software (Spectra Manager
2.5). Deconvoluted amide I band frequencies and secondary structure
assignments<sup><xref ref-type="bibr" rid="ref70">70</xref></sup> for the peptide alone and
in the presence of the <bold>Os-Tolu</bold> complex were obtained
by evaluating the second-derivative spectrum, which was calculated
using a seven-point Savitsky&#x02013;Golay second-derivative function.
The <bold>Os-Tolu</bold> complex alone was analyzed as a control.</p></sec><sec id="sec4.7"><title>ESI-MS Analysis</title><p>Solutions of NPM1<sub>264&#x02013;277</sub> at a concentration of 50 &#x003bc;M in 15 mM ammonium acetate (pH
= 6.8), alone and in a 1:5 molar ratio with the <bold>Os-Tolu</bold> complex, were incubated for 2 h. The mixtures were diluted 10 times
and then analyzed using an LTQ XL Ion Trap mass spectrometer equipped
with an electrospray ionization (ESI) source (Thermo Fisher Scientific).
Peptides and complexes alone were evaluated as controls.</p></sec><sec id="sec4.8"><title>SEM Analysis</title><p>NPM1<sub>264&#x02013;277</sub> alone (100
&#x003bc;M) and NPM1<sub>264&#x02013;277</sub> in the presence of the <bold>Os-Tolu</bold> complex (1:1 peptide:/metal complex molar ratio) were
morphologically analyzed after 4h of aggregation using field-emission
SEM (Phenom_XL, Alfatest, Milan, Italy). After this time, &#x0223c;50
&#x003bc;L of the solution was drop-cast on an aluminum stub and dried
under a vacuum to prepare the samples. For 75 s, a thin layer of gold
was sputtered at a current of 25 mA. Following the introduction of
the sputter-coated samples into the specimen chamber, micrographs
were taken using a secondary electron detector (SED) at an accelerating
voltage of 10 kV. The <bold>Os-Tolu</bold> complex alone (100 &#x003bc;M)
was analyzed as a control.</p></sec><sec id="sec4.9"><title>Cells</title><p>SH-SY5Y cells were grown at 37 &#x000b0;C in a humidified
atmosphere of 5% CO<sub>2</sub> in Eagle&#x02019;s minimum essential
medium (EMEM, Sigma-Aldrich MCF7) and Dulbecco&#x02019;s modified Eagle&#x02019;s
medium and Ham&#x02019;s F12 (DMEM/F-12, SH-SY5Y) containing 10% fetal
bovine serum (FBS), 100 &#x003bc;g mL<sup>&#x02013;1</sup><sc>l</sc>-glutamine, and 100 U mL<sup>&#x02013;1</sup> penicillin/streptomycin.
SH-SY5Y cells were seeded in duplicates in 96-well plates at a density
of 25,000 cells/well and allowed to adhere overnight.</p></sec><sec id="sec4.10"><title>MTT Assay</title><p>NPM1<sub>264&#x02013;277</sub> (stock solution
500 &#x003bc;M in 50 mM phosphate buffer at pH 7.4) in the absence and
NPM1<sub>264&#x02013;277</sub> in the presence of the <bold>Os-Tolu</bold> complex at a 1:1 peptide to metal complex molar ratio (after 0 and
2 h of stirring) were diluted in a cell culture medium at a final
concentration of 100 &#x003bc;M and added to the cells for 24 h. Control
cells were incubated with phosphate buffer diluted in the cell culture
medium at the same final concentration used for the peptide. After
the incubation, MTT assays were used according to the manufacturer&#x02019;s
instructions. Briefly, 200 &#x003bc;L of the MTT labeling reagent (final
concentration, 0.5 mg/mL; Sigma-Aldrich) was added to each well for
3 h. Then, the supernatant was removed and substituted with 200 &#x003bc;L
of isopropanol for 10 min at 37 &#x000b0;C and 5% CO<sub>2</sub>. The
optical density of each well sample was determined at 570 nm using
a microplate reader. A blank absorbance value of 0.21, obtained from
wells without cells but treated with the MTT reagent, was subtracted
from all of the absorbance values. Then, the average absorbance value
of cells treated with the NPM1<sub>264&#x02013;277</sub> peptide was
normalized to those of control cells incubated with the buffer, and
cell viability was expressed as a percentage of the control.</p></sec></sec></body><back><notes id="notes1" notes-type="si"><title>Supporting Information Available</title><p>The Supporting
Information is
available free of charge at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/10.1021/acs.inorgchem.4c04823?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.inorgchem.4c04823</ext-link>.<list id="silist" list-type="simple"><list-item><p><sup>1</sup>H NMR spectrum of <bold>Os-Tolu</bold> in
CDCl<sub>3</sub> at 298 K (Figure S1); <sup>1</sup>H NMR spectrum
of <bold>Os-Tolu</bold> in CD<sub>3</sub>OD at 298 K (Figure S2); <sup>1</sup>H&#x02013;<sup>1</sup>H COSY NMR spectrum of <bold>Os-Tolu</bold> in CDCl<sub>3</sub> at 263 K (Figure S3); <sup>13</sup>C NMR spectrum
of <bold>Os-Tolu</bold> in CDCl<sub>3</sub> at 263 K (Figure S4);
overlay of (A) UV&#x02013;vis spectra (B) fluorescence emission spectra:
&#x003bb;<sub>exc</sub>= 440 nm of <bold>Os-Tolu</bold> (Figure S5); <bold>Os-Tolu</bold> (A) CD spectrum, (B) ESI-MS spectrum at <italic>t</italic> = 2 h of aggregation and (C) SEM microscopy image at <italic>t</italic> = 4 h of aggregation (Figure S6); comparison of <italic>m</italic>/<italic>z</italic> (<italic>z</italic> = +2) isotopic pattern of
experimental (left black panel) and simulated (right red panel) spectra
(Figure S7) (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.inorgchem.4c04823/suppl_file/ic4c04823_si_001.pdf">PDF</ext-link>)</p></list-item></list></p></notes><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="sifile1"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ic4c04823_si_001.pdf"><caption><p>ic4c04823_si_001.pdf</p></caption></media></supplementary-material></sec><notes notes-type="" id="notes2"><title>Author Present Address</title><p><sup>&#x02020;</sup> A.A.'s
present address: IMDEA Nanociencia, Faraday 9, 28049 Madrid,
Spain</p></notes><notes notes-type="" id="notes3"><title>Author Contributions</title><p>D.F. synthesized
the peptides and performed spectroscopic and microscopic investigations;
F.R. and A.A. provided complexes and discussed obtained results, V.P.
and P.A.N. performed cellular experiments; D.M., D.F., and A.A. designed
the concept and supervised the experiments; D.M. and A.A. wrote the
manuscript. All authors have given approval to the final version of
the manuscript.</p></notes><notes notes-type="funding-statement" id="notes4"><p>This work was
supported by #NEXTGENERATIONEU (NGEU), Ministry of University and
Research (MUR), National Recovery and Resilience Plan (NRRP), and
project MNESYS (PE0000006)&#x02014;A Multiscale Integrated Approach
to the Study of the Nervous System in Health and Disease (DN. 1553
11.10.2022) and partially by Associazione Italiana per la Ricerca
sul Cancro (AIRC) grant IG 2022, Rif. 27378 (D.M.).</p></notes><notes notes-type="COI-statement" id="notes5"><p>The authors
declare no competing financial interest.</p></notes><ack><title>Acknowledgments</title><p>The Italian Ministry of Health&#x02013;Ricerca Corrente
Project.</p></ack><glossary id="dl1"><def-list><title>ABBREVIATIONS</title><def-item><term>CD</term><def><p>circular
dichroism</p></def></def-item><def-item><term>DMEM</term><def><p>Dulbecco&#x02019;s
modified Eagle&#x02019;s
medium</p></def></def-item><def-item><term>EMEM</term><def><p>Eagle&#x02019;s
minimum essential medium</p></def></def-item><def-item><term>ESI-MS</term><def><p>electrospray ionization mass spectrometry</p></def></def-item><def-item><term>FBS</term><def><p>fetal bovine serum</p></def></def-item><def-item><term>FTIR</term><def><p>Fourier transform infrared
spectroscopy</p></def></def-item><def-item><term>HFIP</term><def><p>1,1,1,3,3,3-hexafluoro-2-propanol</p></def></def-item><def-item><term>MTT</term><def><p>3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide</p></def></def-item><def-item><term>NHC</term><def><p>N-heterocyclic
carbene</p></def></def-item><def-item><term>NPM1</term><def><p>nucleophosmin
1</p></def></def-item><def-item><term>SEM</term><def><p>scanning electron
microscopy</p></def></def-item><def-item><term>SH-SY5Y</term><def><p>human neuroblastoma cell line</p></def></def-item><def-item><term>ThT</term><def><p>thioflavin T</p></def></def-item></def-list></glossary><ref-list><title>References</title><ref id="ref1"><mixed-citation publication-type="journal" id="cit1"><name><surname>Mjos</surname><given-names>K. D.</given-names></name>; <name><surname>Orvig</surname><given-names>C.</given-names></name>
<article-title>Metallodrugs in Medicinal Inorganic Chemistry</article-title>. <source>Chem. Rev.</source>
<year>2014</year>, <volume>114</volume> (<issue>8</issue>), <fpage>4540</fpage>&#x02013;<lpage>4563</lpage>. <pub-id pub-id-type="doi">10.1021/cr400460s</pub-id>.<pub-id pub-id-type="pmid">24456146</pub-id>
</mixed-citation></ref><ref id="ref2"><mixed-citation publication-type="journal" id="cit2"><name><surname>Anthony</surname><given-names>E. J.</given-names></name>; <name><surname>Bolitho</surname><given-names>E. M.</given-names></name>; <name><surname>Bridgewater</surname><given-names>H. E.</given-names></name>; <name><surname>Carter</surname><given-names>O. W. L.</given-names></name>; <name><surname>Donnelly</surname><given-names>J. M.</given-names></name>; <name><surname>Imberti</surname><given-names>C.</given-names></name>; <name><surname>Lant</surname><given-names>E. C.</given-names></name>; <name><surname>Lermyte</surname><given-names>F.</given-names></name>; <name><surname>Needham</surname><given-names>R. J.</given-names></name>; <name><surname>Palau</surname><given-names>M.</given-names></name>; <name><surname>Sadler</surname><given-names>P. J.</given-names></name>; <name><surname>Shi</surname><given-names>H.</given-names></name>; <name><surname>Wang</surname><given-names>F.-X.</given-names></name>; <name><surname>Zhang</surname><given-names>W.-Y.</given-names></name>; <name><surname>Zhang</surname><given-names>Z.</given-names></name>
<article-title>Metallodrugs Are Unique: Opportunities
and Challenges of Discovery and Development</article-title>. <source>Chem. Sci.</source>
<year>2020</year>, <volume>11</volume> (<issue>48</issue>), <fpage>12888</fpage>&#x02013;<lpage>12917</lpage>. <pub-id pub-id-type="doi">10.1039/D0SC04082G</pub-id>.<pub-id pub-id-type="pmid">34123239</pub-id>
</mixed-citation></ref><ref id="ref3"><mixed-citation publication-type="journal" id="cit3"><name><surname>Boros</surname><given-names>E.</given-names></name>; <name><surname>Dyson</surname><given-names>P. J.</given-names></name>; <name><surname>Gasser</surname><given-names>G.</given-names></name>
<article-title>Classification of Metal-Based Drugs
According to Their Mechanisms of Action</article-title>. <source>Chem.</source>
<year>2020</year>, <volume>6</volume> (<issue>1</issue>), <fpage>41</fpage>&#x02013;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1016/j.chempr.2019.10.013</pub-id>.<pub-id pub-id-type="pmid">32864503</pub-id>
</mixed-citation></ref><ref id="ref4"><mixed-citation publication-type="journal" id="cit4"><name><surname>Annunziata</surname><given-names>A.</given-names></name>; <name><surname>Cucciolito</surname><given-names>M. E.</given-names></name>; <name><surname>Esposito</surname><given-names>R.</given-names></name>; <name><surname>Ferraro</surname><given-names>G.</given-names></name>; <name><surname>Monti</surname><given-names>D. M.</given-names></name>; <name><surname>Merlino</surname><given-names>A.</given-names></name>; <name><surname>Ruffo</surname><given-names>F.</given-names></name>
<article-title>Five-coordinate Platinum(II) Compounds
as Potential Anticancer Agents</article-title>. <source>Eur. J. Inorg.
Chem.</source>
<year>2020</year>, <fpage>918</fpage><pub-id pub-id-type="doi">10.1002/ejic.201900771</pub-id>.</mixed-citation></ref><ref id="ref5"><mixed-citation publication-type="journal" id="cit5"><name><surname>Hayne</surname><given-names>D. J.</given-names></name>; <name><surname>Lim</surname><given-names>S.</given-names></name>; <name><surname>Donnelly</surname><given-names>P. S.</given-names></name>
<article-title>Metal Complexes Designed to Bind to Amyloid-&#x003b2;
for the Diagnosis and Treatment of Alzheimer&#x02019;s Disease</article-title>. <source>Chem. Soc. Rev.</source>
<year>2014</year>, <volume>43</volume> (<issue>19</issue>), <fpage>6701</fpage>&#x02013;<lpage>6715</lpage>. <pub-id pub-id-type="doi">10.1039/C4CS00026A</pub-id>.<pub-id pub-id-type="pmid">24671229</pub-id>
</mixed-citation></ref><ref id="ref6"><mixed-citation publication-type="journal" id="cit6"><name><surname>Spinello</surname><given-names>A.</given-names></name>; <name><surname>Bonsignore</surname><given-names>R.</given-names></name>; <name><surname>Barone</surname><given-names>G.</given-names></name>; <name><surname>Keppler</surname><given-names>K. B.</given-names></name>; <name><surname>Terenzi</surname><given-names>A.</given-names></name>
<article-title>Metal Ions
and Metal Complexes in Alzheimer&#x02019;s Disease</article-title>. <source>Curr. Pharm. Des.</source>
<year>2016</year>, <volume>22</volume> (<issue>26</issue>), <fpage>3996</fpage>&#x02013;<lpage>4010</lpage>. <pub-id pub-id-type="doi">10.2174/1381612822666160520115248</pub-id>.<pub-id pub-id-type="pmid">27197799</pub-id>
</mixed-citation></ref><ref id="ref7"><mixed-citation publication-type="journal" id="cit7"><name><surname>Liu</surname><given-names>H.</given-names></name>; <name><surname>Qu</surname><given-names>Y.</given-names></name>; <name><surname>Wang</surname><given-names>X.</given-names></name>
<article-title>Amyloid &#x003b2;-Targeted
Metal Complexes for Potential
Applications in Alzheimer&#x02019;s Disease</article-title>. <source>Future Med. Chem.</source>
<year>2018</year>, <volume>10</volume> (<issue>6</issue>), <fpage>679</fpage>&#x02013;<lpage>701</lpage>. <pub-id pub-id-type="doi">10.4155/fmc-2017-0248</pub-id>.<pub-id pub-id-type="pmid">29400551</pub-id>
</mixed-citation></ref><ref id="ref8"><mixed-citation publication-type="journal" id="cit8"><name><surname>Webb</surname><given-names>M. I.</given-names></name>
<article-title>The Design
of Metal Complexes to Target the Amyloid-&#x003b2; Peptide in Alzheimer&#x02019;s
Disease</article-title>. <source>In Encyclopedia of Inorganic and Bioinorganic
Chemistry</source>
<year>2023</year>, <fpage>1</fpage>&#x02013;<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1002/9781119951438.eibc2846</pub-id>.</mixed-citation></ref><ref id="ref9"><mixed-citation publication-type="journal" id="cit9"><name><surname>Chiti</surname><given-names>F.</given-names></name>; <name><surname>Dobson</surname><given-names>C. M.</given-names></name>
<article-title>Protein Misfolding,
Amyloid Formation, and Human Disease:
A Summary of Progress Over the Last Decade</article-title>. <source>Annu. Rev. Biochem.</source>
<year>2017</year>, <volume>86</volume> (<issue>1</issue>), <fpage>27</fpage>&#x02013;<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-biochem-061516-045115</pub-id>.<pub-id pub-id-type="pmid">28498720</pub-id>
</mixed-citation></ref><ref id="ref10"><mixed-citation publication-type="journal" id="cit10"><name><surname>Florio</surname><given-names>D.</given-names></name>; <name><surname>Malfitano</surname><given-names>A. M.</given-names></name>; <name><surname>Di Somma</surname><given-names>S.</given-names></name>; <name><surname>M&#x000fc;gge</surname><given-names>C.</given-names></name>; <name><surname>Weigand</surname><given-names>W.</given-names></name>; <name><surname>Ferraro</surname><given-names>G.</given-names></name>; <name><surname>Iacobucci</surname><given-names>I.</given-names></name>; <name><surname>Monti</surname><given-names>M.</given-names></name>; <name><surname>Morelli</surname><given-names>G.</given-names></name>; <name><surname>Merlino</surname><given-names>A.</given-names></name>; <name><surname>Marasco</surname><given-names>D.</given-names></name>
<article-title>Platinum(II)
O,S Complexes Inhibit the Aggregation of Amyloid Model Systems</article-title>. <source>Int. J. Mol. Sci.</source>
<year>2019</year>, <volume>20</volume> (<issue>4</issue>), <fpage>829</fpage><pub-id pub-id-type="doi">10.3390/ijms20040829</pub-id>.<pub-id pub-id-type="pmid">30769904</pub-id>
</mixed-citation></ref><ref id="ref11"><mixed-citation publication-type="journal" id="cit11"><name><surname>Florio</surname><given-names>D.</given-names></name>; <name><surname>Iacobucci</surname><given-names>I.</given-names></name>; <name><surname>Ferraro</surname><given-names>G.</given-names></name>; <name><surname>Mansour</surname><given-names>A. M.</given-names></name>; <name><surname>Morelli</surname><given-names>G.</given-names></name>; <name><surname>Monti</surname><given-names>M.</given-names></name>; <name><surname>Merlino</surname><given-names>A.</given-names></name>; <name><surname>Marasco</surname><given-names>D.</given-names></name>
<article-title>Role of the Metal Center
in the Modulation of the Aggregation Process of Amyloid Model Systems
by Square Planar Complexes Bearing 2-(2&#x02032;-Pyridyl)Benzimidazole
Ligands</article-title>. <source>Pharmaceuticals</source>
<year>2019</year>, <volume>12</volume> (<issue>4</issue>), <fpage>154</fpage><pub-id pub-id-type="doi">10.3390/ph12040154</pub-id>.<pub-id pub-id-type="pmid">31614832</pub-id>
</mixed-citation></ref><ref id="ref12"><mixed-citation publication-type="journal" id="cit12"><name><surname>Barnham</surname><given-names>K. J.</given-names></name>; <name><surname>Kenche</surname><given-names>V. B.</given-names></name>; <name><surname>Ciccotosto</surname><given-names>G. D.</given-names></name>; <name><surname>Smith</surname><given-names>D. P.</given-names></name>; <name><surname>Tew</surname><given-names>D. J.</given-names></name>; <name><surname>Liu</surname><given-names>X.</given-names></name>; <name><surname>Perez</surname><given-names>K.</given-names></name>; <name><surname>Cranston</surname><given-names>G. A.</given-names></name>; <name><surname>Johanssen</surname><given-names>T. J.</given-names></name>; <name><surname>Volitakis</surname><given-names>I.</given-names></name>; <name><surname>Bush</surname><given-names>A. I.</given-names></name>; <name><surname>Masters</surname><given-names>C. L.</given-names></name>; <name><surname>White</surname><given-names>A. R.</given-names></name>; <name><surname>Smith</surname><given-names>J. P.</given-names></name>; <name><surname>Cherny</surname><given-names>R. A.</given-names></name>; <name><surname>Cappai</surname><given-names>R.</given-names></name>
<article-title>Platinum-Based Inhibitors
of Amyloid-&#x003b2; as Therapeutic Agents for Alzheimer&#x02019;s Disease</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source>
<year>2008</year>, <volume>105</volume> (<issue>19</issue>), <fpage>6813</fpage>&#x02013;<lpage>6818</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0800712105</pub-id>.<pub-id pub-id-type="pmid">18463291</pub-id>
</mixed-citation></ref><ref id="ref13"><mixed-citation publication-type="journal" id="cit13"><name><surname>Sasaki</surname><given-names>I.</given-names></name>; <name><surname>Bijani</surname><given-names>C.</given-names></name>; <name><surname>Ladeira</surname><given-names>S.</given-names></name>; <name><surname>Bourdon</surname><given-names>V.</given-names></name>; <name><surname>Faller</surname><given-names>P.</given-names></name>; <name><surname>Hureau</surname><given-names>C.</given-names></name>
<article-title>Interference of a New
Cyclometallated Pt Compound with
Cu Binding to Amyloid-&#x003b2; Peptide</article-title>. <source>Dalton
Trans.</source>
<year>2012</year>, <volume>41</volume> (<issue>21</issue>), <fpage>6404</fpage>&#x02013;<lpage>6407</lpage>. <pub-id pub-id-type="doi">10.1039/c2dt12177h</pub-id>.<pub-id pub-id-type="pmid">22301852</pub-id>
</mixed-citation></ref><ref id="ref14"><mixed-citation publication-type="journal" id="cit14"><name><surname>Collin</surname><given-names>F.</given-names></name>; <name><surname>Sasaki</surname><given-names>I.</given-names></name>; <name><surname>Eury</surname><given-names>H.</given-names></name>; <name><surname>Faller</surname><given-names>P.</given-names></name>; <name><surname>Hureau</surname><given-names>C.</given-names></name>
<article-title>Pt(Ii) Compounds
Interplay with Cu(Ii) and Zn(Ii) Coordination to the Amyloid-&#x003b2;
Peptide Has Metal Specific Consequences on Deleterious Processes Associated
to Alzheimer&#x02019;s Disease</article-title>. <source>Chem. Commun.</source>
<year>2013</year>, <volume>49</volume> (<issue>21</issue>), <fpage>2130</fpage>&#x02013;<lpage>2132</lpage>. <pub-id pub-id-type="doi">10.1039/c3cc38537j</pub-id>.</mixed-citation></ref><ref id="ref15"><mixed-citation publication-type="journal" id="cit15"><name><surname>Wang</surname><given-names>X.</given-names></name>; <name><surname>Cui</surname><given-names>M.</given-names></name>; <name><surname>Zhao</surname><given-names>C.</given-names></name>; <name><surname>He</surname><given-names>L.</given-names></name>; <name><surname>Zhu</surname><given-names>D.</given-names></name>; <name><surname>Wang</surname><given-names>B.</given-names></name>; <name><surname>Du</surname><given-names>W.</given-names></name>
<article-title>Regulation of Aggregation
Behavior and Neurotoxicity of Prion Neuropeptides
by Platinum Complexes</article-title>. <source>Inorg. Chem.</source>
<year>2014</year>, <volume>53</volume> (<issue>10</issue>), <fpage>5044</fpage>&#x02013;<lpage>5054</lpage>. <pub-id pub-id-type="doi">10.1021/ic500092t</pub-id>.<pub-id pub-id-type="pmid">24787240</pub-id>
</mixed-citation></ref><ref id="ref16"><mixed-citation publication-type="journal" id="cit16"><name><surname>Florio</surname><given-names>D.</given-names></name>; <name><surname>Cuomo</surname><given-names>M.</given-names></name>; <name><surname>Iacobucci</surname><given-names>I.</given-names></name>; <name><surname>Ferraro</surname><given-names>G.</given-names></name>; <name><surname>Mansour</surname><given-names>A. M.</given-names></name>; <name><surname>Monti</surname><given-names>M.</given-names></name>; <name><surname>Merlino</surname><given-names>A.</given-names></name>; <name><surname>Marasco</surname><given-names>D.</given-names></name>
<article-title>Modulation of Amyloidogenic
Peptide Aggregation by Photoactivatable CO-Releasing Ruthenium(II)
Complexes</article-title>. <source>Pharmaceuticals</source>
<year>2020</year>, <volume>13</volume> (<issue>8</issue>), <fpage>171</fpage><pub-id pub-id-type="doi">10.3390/ph13080171</pub-id>.<pub-id pub-id-type="pmid">32751396</pub-id>
</mixed-citation></ref><ref id="ref17"><mixed-citation publication-type="journal" id="cit17"><name><surname>La
Manna</surname><given-names>S.</given-names></name>; <name><surname>Di Natale</surname><given-names>C.</given-names></name>; <name><surname>Panzetta</surname><given-names>V.</given-names></name>; <name><surname>Leone</surname><given-names>M.</given-names></name>; <name><surname>Mercurio</surname><given-names>F. A.</given-names></name>; <name><surname>Cipollone</surname><given-names>I.</given-names></name>; <name><surname>Monti</surname><given-names>M.</given-names></name>; <name><surname>Netti</surname><given-names>P. A.</given-names></name>; <name><surname>Ferraro</surname><given-names>G.</given-names></name>; <name><surname>Ter&#x000e1;n</surname><given-names>A.</given-names></name>; <name><surname>S&#x000e1;nchez-Pel&#x000e1;ez</surname><given-names>A. E.</given-names></name>; <name><surname>Herrero</surname><given-names>S.</given-names></name>; <name><surname>Merlino</surname><given-names>A.</given-names></name>; <name><surname>Marasco</surname><given-names>D.</given-names></name>
<article-title>A Diruthenium Metallodrug
as a Potent Inhibitor of Amyloid-&#x003b2; Aggregation: Synergism of
Mechanisms of Action</article-title>. <source>Inorg. Chem.</source>
<year>2024</year>, <volume>63</volume> (<issue>1</issue>), <fpage>564</fpage>&#x02013;<lpage>575</lpage>. <pub-id pub-id-type="doi">10.1021/acs.inorgchem.3c03441</pub-id>.<pub-id pub-id-type="pmid">38117944</pub-id>
</mixed-citation></ref><ref id="ref18"><mixed-citation publication-type="journal" id="cit18"><name><surname>Makanyane</surname><given-names>D. M.</given-names></name>; <name><surname>Maikoo</surname><given-names>S.</given-names></name>; <name><surname>Van Heerden</surname><given-names>F. R.</given-names></name>; <name><surname>Rhyman</surname><given-names>L.</given-names></name>; <name><surname>Ramasami</surname><given-names>P.</given-names></name>; <name><surname>Mabuza</surname><given-names>L. P.</given-names></name>; <name><surname>Ngubane</surname><given-names>P.</given-names></name>; <name><surname>Khathi</surname><given-names>A.</given-names></name>; <name><surname>Mambanda</surname><given-names>A.</given-names></name>; <name><surname>Booysen</surname><given-names>I. N.</given-names></name>
<article-title>Bovine Serum Albumin
Uptake and Polypeptide Disaggregation
Studies of Hypoglycemic Ruthenium(II) Uracil Schiff-Base Complexes</article-title>. <source>Journal of Inorganic Biochemistry</source>
<year>2024</year>, <volume>255</volume>, <elocation-id>112541</elocation-id><pub-id pub-id-type="doi">10.1016/j.jinorgbio.2024.112541</pub-id>.<pub-id pub-id-type="pmid">38554578</pub-id>
</mixed-citation></ref><ref id="ref19"><mixed-citation publication-type="journal" id="cit19"><name><surname>Messori</surname><given-names>L.</given-names></name>; <name><surname>Camarri</surname><given-names>M.</given-names></name>; <name><surname>Ferraro</surname><given-names>T.</given-names></name>; <name><surname>Gabbiani</surname><given-names>C.</given-names></name>; <name><surname>Franceschini</surname><given-names>D.</given-names></name>
<article-title>Promising
in Vitro Anti-Alzheimer Properties for a Ruthenium(III) Complex</article-title>. <source>ACS Med. Chem. Lett.</source>
<year>2013</year>, <volume>4</volume> (<issue>3</issue>), <fpage>329</fpage>&#x02013;<lpage>332</lpage>. <pub-id pub-id-type="doi">10.1021/ml3003567</pub-id>.<pub-id pub-id-type="pmid">24900669</pub-id>
</mixed-citation></ref><ref id="ref20"><mixed-citation publication-type="journal" id="cit20"><name><surname>Yawson</surname><given-names>G. K.</given-names></name>; <name><surname>Huffman</surname><given-names>S. E.</given-names></name>; <name><surname>Fisher</surname><given-names>S. S.</given-names></name>; <name><surname>Bothwell</surname><given-names>P. J.</given-names></name>; <name><surname>Platt</surname><given-names>D. C.</given-names></name>; <name><surname>Jones</surname><given-names>M. A.</given-names></name>; <name><surname>Ferrence</surname><given-names>G. M.</given-names></name>; <name><surname>Hamaker</surname><given-names>C. G.</given-names></name>; <name><surname>Webb</surname><given-names>M. I.</given-names></name>
<article-title>Ruthenium(III)
Complexes with Imidazole Ligands That Modulate the Aggregation of
the Amyloid-&#x003b2; Peptide via Hydrophobic Interactions</article-title>. <source>Journal of Inorganic Biochemistry</source>
<year>2021</year>, <volume>214</volume>, <elocation-id>111303</elocation-id><pub-id pub-id-type="doi">10.1016/j.jinorgbio.2020.111303</pub-id>.<pub-id pub-id-type="pmid">33166864</pub-id>
</mixed-citation></ref><ref id="ref21"><mixed-citation publication-type="journal" id="cit21"><name><surname>Yawson</surname><given-names>G. K.</given-names></name>; <name><surname>Will</surname><given-names>M. F.</given-names></name>; <name><surname>Huffman</surname><given-names>S. E.</given-names></name>; <name><surname>Strandquist</surname><given-names>E. T.</given-names></name>; <name><surname>Bothwell</surname><given-names>P. J.</given-names></name>; <name><surname>Oliver</surname><given-names>E. B.</given-names></name>; <name><surname>Apuzzo</surname><given-names>C. F.</given-names></name>; <name><surname>Platt</surname><given-names>D. C.</given-names></name>; <name><surname>Weitzel</surname><given-names>C. S.</given-names></name>; <name><surname>Jones</surname><given-names>M. A.</given-names></name>; <name><surname>Ferrence</surname><given-names>G. M.</given-names></name>; <name><surname>Hamaker</surname><given-names>C. G.</given-names></name>; <name><surname>Webb</surname><given-names>M. I.</given-names></name>
<article-title>A Dual-Pronged Approach: A Ruthenium(III)
Complex That
Modulates Amyloid-&#x003b2; Aggregation and Disrupts Its Formed Aggregates</article-title>. <source>Inorg. Chem.</source>
<year>2022</year>, <volume>61</volume> (<issue>6</issue>), <fpage>2733</fpage>&#x02013;<lpage>2744</lpage>. <pub-id pub-id-type="doi">10.1021/acs.inorgchem.1c01651</pub-id>.<pub-id pub-id-type="pmid">35102739</pub-id>
</mixed-citation></ref><ref id="ref22"><mixed-citation publication-type="journal" id="cit22"><name><surname>Ehlbeck</surname><given-names>J. T.</given-names></name>; <name><surname>Grimard</surname><given-names>D. M.</given-names></name>; <name><surname>Hacker</surname><given-names>R. M.</given-names></name>; <name><surname>Garcia</surname><given-names>J. A.</given-names></name>; <name><surname>Wall</surname><given-names>B. J.</given-names></name>; <name><surname>Bothwell</surname><given-names>P. J.</given-names></name>; <name><surname>Jones</surname><given-names>M. A.</given-names></name>; <name><surname>Webb</surname><given-names>M. I.</given-names></name>
<article-title>Finding the Best
Location: Improving the Anti-Amyloid Ability of Ruthenium(III) Complexes
with Pyridine Ligands</article-title>. <source>Journal of Inorganic
Biochemistry</source>
<year>2024</year>, <volume>250</volume>, <elocation-id>112424</elocation-id><pub-id pub-id-type="doi">10.1016/j.jinorgbio.2023.112424</pub-id>.<pub-id pub-id-type="pmid">37952508</pub-id>
</mixed-citation></ref><ref id="ref23"><mixed-citation publication-type="journal" id="cit23"><name><surname>La
Manna</surname><given-names>S.</given-names></name>; <name><surname>Panzetta</surname><given-names>V.</given-names></name>; <name><surname>Di Natale</surname><given-names>C.</given-names></name>; <name><surname>Cipollone</surname><given-names>I.</given-names></name>; <name><surname>Monti</surname><given-names>M.</given-names></name>; <name><surname>Netti</surname><given-names>P. A.</given-names></name>; <name><surname>Ter&#x000e1;n</surname><given-names>A.</given-names></name>; <name><surname>S&#x000e1;nchez-Pel&#x000e1;ez</surname><given-names>A. E.</given-names></name>; <name><surname>Herrero</surname><given-names>S.</given-names></name>; <name><surname>Merlino</surname><given-names>A.</given-names></name>; <name><surname>Marasco</surname><given-names>D.</given-names></name>
<article-title>Comparative Analysis of the Inhibitory Mechanism of
A&#x003b2;1&#x02013;42 Aggregation by Diruthenium Complexes</article-title>. <source>Inorg. Chem.</source>
<year>2024</year>, <volume>63</volume> (<issue>21</issue>), <fpage>10001</fpage>&#x02013;<lpage>10010</lpage>. <pub-id pub-id-type="doi">10.1021/acs.inorgchem.4c01218</pub-id>.<pub-id pub-id-type="pmid">38742626</pub-id>
</mixed-citation></ref><ref id="ref24"><mixed-citation publication-type="journal" id="cit24"><name><surname>Cucciolito</surname><given-names>M. E.</given-names></name>; <name><surname>D&#x02019;Amora</surname><given-names>A.</given-names></name>; <name><surname>De Feo</surname><given-names>G.</given-names></name>; <name><surname>Ferraro</surname><given-names>G.</given-names></name>; <name><surname>Giorgio</surname><given-names>A.</given-names></name>; <name><surname>Petruk</surname><given-names>G.</given-names></name>; <name><surname>Monti</surname><given-names>D. M.</given-names></name>; <name><surname>Merlino</surname><given-names>A.</given-names></name>; <name><surname>Ruffo</surname><given-names>F.</given-names></name>
<article-title>Five-Coordinate
Platinum(II) Compounds Containing Sugar Ligands: Synthesis, Characterization,
Cytotoxic Activity, and Interaction with Biological Macromolecules</article-title>. <source>Inorg. Chem.</source>
<year>2018</year>, <volume>57</volume> (<issue>6</issue>), <fpage>3133</fpage>&#x02013;<lpage>3143</lpage>. <pub-id pub-id-type="doi">10.1021/acs.inorgchem.7b03118</pub-id>.<pub-id pub-id-type="pmid">29509011</pub-id>
</mixed-citation></ref><ref id="ref25"><mixed-citation publication-type="journal" id="cit25"><name><surname>Cucciolito</surname><given-names>M. E.</given-names></name>; <name><surname>De Luca Bossa</surname><given-names>F.</given-names></name>; <name><surname>Esposito</surname><given-names>R.</given-names></name>; <name><surname>Ferraro</surname><given-names>G.</given-names></name>; <name><surname>Iadonisi</surname><given-names>A.</given-names></name>; <name><surname>Petruk</surname><given-names>G.</given-names></name>; <name><surname>D&#x02019;Elia</surname><given-names>L.</given-names></name>; <name><surname>Romanetti</surname><given-names>C.</given-names></name>; <name><surname>Traboni</surname><given-names>S.</given-names></name>; <name><surname>Tuzi</surname><given-names>A.</given-names></name>; <name><surname>Monti</surname><given-names>D. M.</given-names></name>; <name><surname>Merlino</surname><given-names>A.</given-names></name>; <name><surname>Ruffo</surname><given-names>F.</given-names></name>
<article-title>C-Glycosylation in
Platinum-Based Agents: A Viable Strategy to Improve
Cytotoxicity and Selectivity</article-title>. <source>Inorg. Chem. Front.</source>
<year>2018</year>, <volume>5</volume> (<issue>11</issue>), <fpage>2921</fpage>&#x02013;<lpage>2933</lpage>. <pub-id pub-id-type="doi">10.1039/C8QI00664D</pub-id>.</mixed-citation></ref><ref id="ref26"><mixed-citation publication-type="journal" id="cit26"><name><surname>Bononi</surname><given-names>G.</given-names></name>; <name><surname>Iacopini</surname><given-names>D.</given-names></name>; <name><surname>Cicio</surname><given-names>G.</given-names></name>; <name><surname>Di Pietro</surname><given-names>S.</given-names></name>; <name><surname>Granchi</surname><given-names>C.</given-names></name>; <name><surname>Di Bussolo</surname><given-names>V.</given-names></name>; <name><surname>Minutolo</surname><given-names>F.</given-names></name>
<article-title>Glycoconjugated Metal
Complexes as Cancer Diagnostic and Therapeutic Agents</article-title>. <source>ChemMedChem.</source>
<year>2021</year>, <volume>16</volume> (<issue>1</issue>), <fpage>30</fpage>&#x02013;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1002/cmdc.202000456</pub-id>.<pub-id pub-id-type="pmid">32735702</pub-id>
</mixed-citation></ref><ref id="ref27"><mixed-citation publication-type="journal" id="cit27"><name><surname>Florio</surname><given-names>D.</given-names></name>; <name><surname>La Manna</surname><given-names>S.</given-names></name>; <name><surname>Annunziata</surname><given-names>A.</given-names></name>; <name><surname>Iacobucci</surname><given-names>I.</given-names></name>; <name><surname>Monaco</surname><given-names>V.</given-names></name>; <name><surname>Di Natale</surname><given-names>C.</given-names></name>; <name><surname>Mollo</surname><given-names>V.</given-names></name>; <name><surname>Ruffo</surname><given-names>F.</given-names></name>; <name><surname>Monti</surname><given-names>M.</given-names></name>; <name><surname>Marasco</surname><given-names>D.</given-names></name>
<article-title>Ruthenium Complexes Bearing Glucosyl
Ligands Are Able to Inhibit the Amyloid Aggregation of Short Histidine-Peptides</article-title>. <source>Dalton Trans.</source>
<year>2023</year>, <volume>52</volume> (<issue>25</issue>), <fpage>8549</fpage>&#x02013;<lpage>8557</lpage>. <pub-id pub-id-type="doi">10.1039/D3DT01110K</pub-id>.<pub-id pub-id-type="pmid">37264643</pub-id>
</mixed-citation></ref><ref id="ref28"><mixed-citation publication-type="journal" id="cit28"><name><surname>Florio</surname><given-names>D.</given-names></name>; <name><surname>Annunziata</surname><given-names>A.</given-names></name>; <name><surname>Panzetta</surname><given-names>V.</given-names></name>; <name><surname>Netti</surname><given-names>P. A.</given-names></name>; <name><surname>Ruffo</surname><given-names>F.</given-names></name>; <name><surname>Marasco</surname><given-names>D.</given-names></name>
<article-title>&#x00397;6-Arene
Ru(II) Complexes as Modulators of Amyloid
Aggregation</article-title>. <source>Inorg. Chem.</source>
<year>2024</year>, <volume>63</volume> (<issue>34</issue>), <fpage>16001</fpage>&#x02013;<lpage>16010</lpage>. <pub-id pub-id-type="doi">10.1021/acs.inorgchem.4c02456</pub-id>.<pub-id pub-id-type="pmid">39129368</pub-id>
</mixed-citation></ref><ref id="ref29"><mixed-citation publication-type="journal" id="cit29"><name><surname>Hanif</surname><given-names>M.</given-names></name>; <name><surname>Babak</surname><given-names>M. V.</given-names></name>; <name><surname>Hartinger</surname><given-names>C. G.</given-names></name>
<article-title>Development
of Anticancer Agents:
Wizardry with Osmium</article-title>. <source>Drug Discovery Today</source>
<year>2014</year>, <volume>19</volume> (<issue>10</issue>), <fpage>1640</fpage>&#x02013;<lpage>1648</lpage>. <pub-id pub-id-type="doi">10.1016/j.drudis.2014.06.016</pub-id>.<pub-id pub-id-type="pmid">24955838</pub-id>
</mixed-citation></ref><ref id="ref30"><mixed-citation publication-type="journal" id="cit30"><name><surname>Stepanenko</surname><given-names>I. N.</given-names></name>; <name><surname>Krokhin</surname><given-names>A. A.</given-names></name>; <name><surname>John</surname><given-names>R. O.</given-names></name>; <name><surname>Roller</surname><given-names>A.</given-names></name>; <name><surname>Arion</surname><given-names>V. B.</given-names></name>; <name><surname>Jakupec</surname><given-names>M. A.</given-names></name>; <name><surname>Keppler</surname><given-names>B. K.</given-names></name>
<article-title>Synthesis, Structure, Spectroscopic
Properties, and Antiproliferative Activity In Vitro of Novel Osmium(III)
Complexes with Azole Heterocycles</article-title>. <source>Inorg. Chem.</source>
<year>2008</year>, <volume>47</volume> (<issue>16</issue>), <fpage>7338</fpage>&#x02013;<lpage>7347</lpage>. <pub-id pub-id-type="doi">10.1021/ic8006958</pub-id>.<pub-id pub-id-type="pmid">18597450</pub-id>
</mixed-citation></ref><ref id="ref31"><mixed-citation publication-type="journal" id="cit31"><name><surname>Kostrhunova</surname><given-names>H.</given-names></name>; <name><surname>Florian</surname><given-names>J.</given-names></name>; <name><surname>Novakova</surname><given-names>O.</given-names></name>; <name><surname>Peacock</surname><given-names>A. F. A.</given-names></name>; <name><surname>Sadler</surname><given-names>P. J.</given-names></name>; <name><surname>Brabec</surname><given-names>V.</given-names></name>
<article-title>DNA Interactions
of Monofunctional Organometallic Osmium(II)
Antitumor Complexes in Cell-Free Media</article-title>. <source>J. Med.
Chem.</source>
<year>2008</year>, <volume>51</volume> (<issue>12</issue>), <fpage>3635</fpage>&#x02013;<lpage>3643</lpage>. <pub-id pub-id-type="doi">10.1021/jm701538w</pub-id>.<pub-id pub-id-type="pmid">18494458</pub-id>
</mixed-citation></ref><ref id="ref32"><mixed-citation publication-type="journal" id="cit32"><name><surname>B&#x000fc;chel</surname><given-names>G. E.</given-names></name>; <name><surname>Stepanenko</surname><given-names>I. N.</given-names></name>; <name><surname>Hejl</surname><given-names>M.</given-names></name>; <name><surname>Jakupec</surname><given-names>M. A.</given-names></name>; <name><surname>Keppler</surname><given-names>B. K.</given-names></name>; <name><surname>Arion</surname><given-names>V. B.</given-names></name>
<article-title>En Route to Osmium Analogues of KP1019: Synthesis,
Structure, Spectroscopic Properties and Antiproliferative Activity
of Trans-[OsIVCl4(Hazole)2]</article-title>. <source>Inorg. Chem.</source>
<year>2011</year>, <volume>50</volume> (<issue>16</issue>), <fpage>7690</fpage>&#x02013;<lpage>7697</lpage>. <pub-id pub-id-type="doi">10.1021/ic200728b</pub-id>.<pub-id pub-id-type="pmid">21739939</pub-id>
</mixed-citation></ref><ref id="ref33"><mixed-citation publication-type="journal" id="cit33"><name><surname>Riedl</surname><given-names>C. A.</given-names></name>; <name><surname>Flocke</surname><given-names>L. S.</given-names></name>; <name><surname>Hejl</surname><given-names>M.</given-names></name>; <name><surname>Roller</surname><given-names>A.</given-names></name>; <name><surname>Klose</surname><given-names>M. H. M.</given-names></name>; <name><surname>Jakupec</surname><given-names>M. A.</given-names></name>; <name><surname>Kandioller</surname><given-names>W.</given-names></name>; <name><surname>Keppler</surname><given-names>B. K.</given-names></name>
<article-title>Introducing the
4-Phenyl-1,2,3-Triazole Moiety as a Versatile Scaffold for the Development
of Cytotoxic Ruthenium(II) and Osmium(II) Arene Cyclometalates</article-title>. <source>Inorg. Chem.</source>
<year>2017</year>, <volume>56</volume> (<issue>1</issue>), <fpage>528</fpage>&#x02013;<lpage>541</lpage>. <pub-id pub-id-type="doi">10.1021/acs.inorgchem.6b02430</pub-id>.<pub-id pub-id-type="pmid">27996251</pub-id>
</mixed-citation></ref><ref id="ref34"><mixed-citation publication-type="journal" id="cit34"><name><surname>Tapala</surname><given-names>K. C.</given-names></name>; <name><surname>Ndlangamandla</surname><given-names>N. G.</given-names></name>; <name><surname>Ngoepe</surname><given-names>M. P.</given-names></name>; <name><surname>Clayton</surname><given-names>H. S.</given-names></name>; <name><surname>Rafique</surname><given-names>J.</given-names></name>
<article-title>Molecular
Structure, Spectroscopic, Frontier Molecular Orbital Analysis, Molecular
Docking Studies, and In Vitro DNA-Binding Studies of Osmium(II)-Cymene
Complexes with Aryl Phosphine and Aryl Phosphonium Assemblies</article-title>. <source>Bioinorg. Chem. Appl.</source>
<year>2024</year>, <volume>2024</volume> (<issue>1</issue>), <elocation-id>6697523</elocation-id><pub-id pub-id-type="doi">10.1155/2024/6697523</pub-id>.<pub-id pub-id-type="pmid">38840845</pub-id>
</mixed-citation></ref><ref id="ref35"><mixed-citation publication-type="journal" id="cit35"><name><surname>Peacock</surname><given-names>A. F. A.</given-names></name>; <name><surname>Habtemariam</surname><given-names>A.</given-names></name>; <name><surname>Moggach</surname><given-names>S. A.</given-names></name>; <name><surname>Prescimone</surname><given-names>A.</given-names></name>; <name><surname>Parsons</surname><given-names>S.</given-names></name>; <name><surname>Sadler</surname><given-names>P. J.</given-names></name>; et al. <source>Inorg. Chem.</source>
<year>2007</year>, <volume>46</volume> (<issue>10</issue>), <fpage>4049</fpage>&#x02013;<lpage>4059</lpage>. <pub-id pub-id-type="doi">10.1021/ic062350d</pub-id>.<pub-id pub-id-type="pmid">17441712</pub-id>
</mixed-citation></ref><ref id="ref36"><mixed-citation publication-type="journal" id="cit36"><name><surname>Fu</surname><given-names>Y.</given-names></name>; <name><surname>Romero</surname><given-names>M. J.</given-names></name>; <name><surname>Habtemariam</surname><given-names>A.</given-names></name>; <name><surname>Snowden</surname><given-names>M. E.</given-names></name>; <name><surname>Song</surname><given-names>L.</given-names></name>; <name><surname>Clarkson</surname><given-names>G. J.</given-names></name>; <name><surname>Qamar</surname><given-names>B.</given-names></name>; <name><surname>Pizarro</surname><given-names>A. M.</given-names></name>; <name><surname>Unwin</surname><given-names>P. R.</given-names></name>; <name><surname>Sadler</surname><given-names>P. J.</given-names></name>
<article-title>The Contrasting
Chemical Reactivity of Potent Isoelectronic
Iminopyridine and Azopyridine Osmium(Ii) Arene Anticancer Complexes</article-title>. <source>Chem. Sci.</source>
<year>2012</year>, <volume>3</volume> (<issue>8</issue>), <fpage>2485</fpage>&#x02013;<lpage>2494</lpage>. <pub-id pub-id-type="doi">10.1039/c2sc20220d</pub-id>.</mixed-citation></ref><ref id="ref37"><mixed-citation publication-type="journal" id="cit37"><name><surname>Needham</surname><given-names>R. J.</given-names></name>; <name><surname>Sanchez-Cano</surname><given-names>C.</given-names></name>; <name><surname>Zhang</surname><given-names>X.</given-names></name>; <name><surname>Romero-Canel&#x000f3;n</surname><given-names>I.</given-names></name>; <name><surname>Habtemariam</surname><given-names>A.</given-names></name>; <name><surname>Cooper</surname><given-names>M. S.</given-names></name>; <name><surname>Meszaros</surname><given-names>L.</given-names></name>; <name><surname>Clarkson</surname><given-names>G. J.</given-names></name>; <name><surname>Blower</surname><given-names>P. J.</given-names></name>; <name><surname>Sadler</surname><given-names>P. J.</given-names></name>
<article-title>In-Cell Activation of Organo-Osmium(II)
Anticancer Complexes</article-title>. <source>Angew. Chem., Int. Ed.</source>
<year>2017</year>, <volume>56</volume> (<issue>4</issue>), <fpage>1017</fpage>&#x02013;<lpage>1020</lpage>. <pub-id pub-id-type="doi">10.1002/anie.201610290</pub-id>.</mixed-citation></ref><ref id="ref38"><mixed-citation publication-type="journal" id="cit38"><name><surname>Hearn</surname><given-names>J. M.</given-names></name>; <name><surname>Hughes</surname><given-names>G. M.</given-names></name>; <name><surname>Romero-Canel&#x000f3;n</surname><given-names>I.</given-names></name>; <name><surname>Munro</surname><given-names>A. F.</given-names></name>; <name><surname>Rubio-Ruiz</surname><given-names>B.</given-names></name>; <name><surname>Liu</surname><given-names>Z.</given-names></name>; <name><surname>Carragher</surname><given-names>N. O.</given-names></name>; <name><surname>Sadler</surname><given-names>P. J.</given-names></name>
<article-title>Pharmaco-Genomic Investigations of Organo-Iridium Anticancer
Complexes Reveal Novel Mechanism of Action&#x02020;</article-title>. <source>Metallomics</source>
<year>2018</year>, <volume>10</volume> (<issue>1</issue>), <fpage>93</fpage>&#x02013;<lpage>107</lpage>. <pub-id pub-id-type="doi">10.1039/C7MT00242D</pub-id>.<pub-id pub-id-type="pmid">29131211</pub-id>
</mixed-citation></ref><ref id="ref39"><mixed-citation publication-type="journal" id="cit39"><name><surname>Bolitho</surname><given-names>E. M.</given-names></name>; <name><surname>Coverdale</surname><given-names>J. P. C.</given-names></name>; <name><surname>Bridgewater</surname><given-names>H. E.</given-names></name>; <name><surname>Clarkson</surname><given-names>G. J.</given-names></name>; <name><surname>Quinn</surname><given-names>P. D.</given-names></name>; <name><surname>Sanchez-Cano</surname><given-names>C.</given-names></name>; <name><surname>Sadler</surname><given-names>P. J.</given-names></name>
<article-title>Tracking Reactions of Asymmetric
Organo-Osmium Transfer Hydrogenation Catalysts in Cancer Cells</article-title>. <source>Angew. Chem., Int. Ed.</source>
<year>2021</year>, <volume>60</volume> (<issue>12</issue>), <fpage>6462</fpage>&#x02013;<lpage>6472</lpage>. <pub-id pub-id-type="doi">10.1002/anie.202016456</pub-id>.</mixed-citation></ref><ref id="ref40"><mixed-citation publication-type="journal" id="cit40"><name><surname>Peacock</surname><given-names>A. F. A.</given-names></name>; <name><surname>Habtemariam</surname><given-names>A.</given-names></name>; <name><surname>Fern&#x000e1;ndez</surname><given-names>R.</given-names></name>; <name><surname>Walland</surname><given-names>V.</given-names></name>; <name><surname>Fabbiani</surname><given-names>F. P. A.</given-names></name>; <name><surname>Parsons</surname><given-names>S.</given-names></name>; <name><surname>Aird</surname><given-names>R. E.</given-names></name>; <name><surname>Jodrell</surname><given-names>D. I.</given-names></name>; <name><surname>Sadler</surname><given-names>P. J.</given-names></name>
<article-title>Tuning
the Reactivity of Osmium(II) and Ruthenium(II) Arene Complexes under
Physiological Conditions</article-title>. <source>J. Am. Chem. Soc.</source>
<year>2006</year>, <volume>128</volume> (<issue>5</issue>), <fpage>1739</fpage>&#x02013;<lpage>1748</lpage>. <pub-id pub-id-type="doi">10.1021/ja055886r</pub-id>.<pub-id pub-id-type="pmid">16448150</pub-id>
</mixed-citation></ref><ref id="ref41"><mixed-citation publication-type="journal" id="cit41"><name><surname>van
Rijt</surname><given-names>S. H.</given-names></name>; <name><surname>Romero-Canel&#x000f3;n</surname><given-names>I.</given-names></name>; <name><surname>Fu</surname><given-names>Y.</given-names></name>; <name><surname>Shnyder</surname><given-names>S. D.</given-names></name>; <name><surname>Sadler</surname><given-names>P. J.</given-names></name>
<article-title>Potent Organometallic Osmium Compounds
Induce Mitochondria-Mediated Apoptosis and S-Phase Cell Cycle Arrest
in A549 Non-Small Cell Lung Cancer Cells</article-title>. <source>Metallomics</source>
<year>2014</year>, <volume>6</volume> (<issue>5</issue>), <fpage>1014</fpage>&#x02013;<lpage>1022</lpage>. <pub-id pub-id-type="doi">10.1039/c4mt00034j</pub-id>.<pub-id pub-id-type="pmid">24668459</pub-id>
</mixed-citation></ref><ref id="ref42"><mixed-citation publication-type="journal" id="cit42"><name><surname>Noyori</surname><given-names>R.</given-names></name>; <name><surname>Hashiguchi</surname><given-names>S.</given-names></name>
<article-title>Asymmetric
Transfer Hydrogenation Catalyzed by Chiral
Ruthenium Complexes</article-title>. <source>Acc. Chem. Res.</source>
<year>1997</year>, <volume>30</volume> (<issue>2</issue>), <fpage>97</fpage>&#x02013;<lpage>102</lpage>. <pub-id pub-id-type="doi">10.1021/ar9502341</pub-id>.</mixed-citation></ref><ref id="ref43"><mixed-citation publication-type="journal" id="cit43"><name><surname>Coverdale</surname><given-names>J. P. C.</given-names></name>; <name><surname>Romero-Canel&#x000f3;n</surname><given-names>I.</given-names></name>; <name><surname>Sanchez-Cano</surname><given-names>C.</given-names></name>; <name><surname>Clarkson</surname><given-names>G. J.</given-names></name>; <name><surname>Habtemariam</surname><given-names>A.</given-names></name>; <name><surname>Wills</surname><given-names>M.</given-names></name>; <name><surname>Sadler</surname><given-names>P. J.</given-names></name>
<article-title>Asymmetric
Transfer Hydrogenation by Synthetic Catalysts in Cancer Cells</article-title>. <source>Nat. Chem.</source>
<year>2018</year>, <volume>10</volume> (<issue>3</issue>), <fpage>347</fpage>&#x02013;<lpage>354</lpage>. <pub-id pub-id-type="doi">10.1038/nchem.2918</pub-id>.<pub-id pub-id-type="pmid">29461524</pub-id>
</mixed-citation></ref><ref id="ref44"><mixed-citation publication-type="journal" id="cit44"><name><surname>Coverdale</surname><given-names>J. P. C.</given-names></name>; <name><surname>Bedford</surname><given-names>R. A.</given-names></name>; <name><surname>Carter</surname><given-names>O. W. L.</given-names></name>; <name><surname>Cao</surname><given-names>S.</given-names></name>; <name><surname>Wills</surname><given-names>M.</given-names></name>; <name><surname>Sadler</surname><given-names>P. J.</given-names></name>
<article-title>In-Cell Catalysis by Tethered Organo-Osmium Complexes
Generates Selectivity for Breast Cancer Cells</article-title>. <source>ChemBioChem</source>
<year>2024</year>, <volume>25</volume>, <elocation-id>e202400374</elocation-id><pub-id pub-id-type="doi">10.1002/cbic.202400374</pub-id>.<pub-id pub-id-type="pmid">38785030</pub-id>
</mixed-citation></ref><ref id="ref45"><mixed-citation publication-type="journal" id="cit45"><name><surname>Infante-Tadeo</surname><given-names>S.</given-names></name>; <name><surname>Rodr&#x000ed;guez-Fanjul</surname><given-names>V.</given-names></name>; <name><surname>Vequi-Suplicy</surname><given-names>C. C.</given-names></name>; <name><surname>Pizarro</surname><given-names>A. M.</given-names></name>
<article-title>Fast Hydrolysis and Strongly Basic
Water Adducts Lead
to Potent Os(II) Half-Sandwich Anticancer Complexes</article-title>. <source>Inorg. Chem.</source>
<year>2022</year>, <volume>61</volume> (<issue>47</issue>), <fpage>18970</fpage>&#x02013;<lpage>18978</lpage>. <pub-id pub-id-type="doi">10.1021/acs.inorgchem.2c03246</pub-id>.<pub-id pub-id-type="pmid">36378547</pub-id>
</mixed-citation></ref><ref id="ref46"><mixed-citation publication-type="journal" id="cit46"><name><surname>Infante-Tadeo</surname><given-names>S.</given-names></name>; <name><surname>Rodr&#x000ed;guez-Fanjul</surname><given-names>V.</given-names></name>; <name><surname>Habtemariam</surname><given-names>A.</given-names></name>; <name><surname>Pizarro</surname><given-names>A. M.</given-names></name>
<article-title>Osmium(<sc>ii</sc>) Tethered Half-Sandwich
Complexes:
pH-Dependent Aqueous Speciation and Transfer Hydrogenation in Cells</article-title>. <source>Chem. Sci.</source>
<year>2021</year>, <volume>12</volume> (<issue>27</issue>), <fpage>9287</fpage>&#x02013;<lpage>9297</lpage>. <pub-id pub-id-type="doi">10.1039/D1SC01939B</pub-id>.<pub-id pub-id-type="pmid">34349898</pub-id>
</mixed-citation></ref><ref id="ref47"><mixed-citation publication-type="journal" id="cit47"><name><surname>Kovalska</surname><given-names>V.</given-names></name>; <name><surname>Chernii</surname><given-names>S.</given-names></name>; <name><surname>Cherepanov</surname><given-names>V.</given-names></name>; <name><surname>Losytskyy</surname><given-names>M.</given-names></name>; <name><surname>Chernii</surname><given-names>V.</given-names></name>; <name><surname>Varzatskii</surname><given-names>O.</given-names></name>; <name><surname>Naumovets</surname><given-names>A.</given-names></name>; <name><surname>Yarmoluk</surname><given-names>S.</given-names></name>
<article-title>The Impact of Binding of Macrocyclic
Metal Complexes
on Amyloid Fibrillization of Insulin and Lysozyme</article-title>. <source>Journal of Molecular Recognition</source>
<year>2017</year>, <volume>30</volume> (<issue>8</issue>), <elocation-id>e2622</elocation-id><pub-id pub-id-type="doi">10.1002/jmr.2622</pub-id>.</mixed-citation></ref><ref id="ref48"><mixed-citation publication-type="journal" id="cit48"><name><surname>Ahmad</surname><given-names>B.</given-names></name>; <name><surname>Borana</surname><given-names>M. S.</given-names></name>; <name><surname>Chaudhary</surname><given-names>A. P.</given-names></name>
<article-title>Understanding
Curcumin-Induced Modulation
of Protein Aggregation</article-title>. <source>Int. J. Biol. Macromol.</source>
<year>2017</year>, <volume>100</volume>, <fpage>89</fpage>&#x02013;<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2016.06.053</pub-id>.<pub-id pub-id-type="pmid">27327907</pub-id>
</mixed-citation></ref><ref id="ref49"><mixed-citation publication-type="journal" id="cit49"><name><surname>Huo</surname><given-names>X.</given-names></name>; <name><surname>Liu</surname><given-names>H.</given-names></name>; <name><surname>Wang</surname><given-names>S.</given-names></name>; <name><surname>Yin</surname><given-names>S.</given-names></name>; <name><surname>Yin</surname><given-names>Z.</given-names></name>
<article-title>The Inhibitory Effect
and Mechanism of Small Molecules on Acetic Anhydride-Induced BSA Acetylation
and Aggregation</article-title>. <source>Colloids Surf., B</source>
<year>2023</year>, <volume>225</volume>, <elocation-id>113265</elocation-id><pub-id pub-id-type="doi">10.1016/j.colsurfb.2023.113265</pub-id>.</mixed-citation></ref><ref id="ref50"><mixed-citation publication-type="journal" id="cit50"><name><surname>Di
Natale</surname><given-names>C.</given-names></name>; <name><surname>Scognamiglio</surname><given-names>P. L.</given-names></name>; <name><surname>Cascella</surname><given-names>R.</given-names></name>; <name><surname>Cecchi</surname><given-names>C.</given-names></name>; <name><surname>Russo</surname><given-names>A.</given-names></name>; <name><surname>Leone</surname><given-names>M.</given-names></name>; <name><surname>Penco</surname><given-names>A.</given-names></name>; <name><surname>Relini</surname><given-names>A.</given-names></name>; <name><surname>Federici</surname><given-names>L.</given-names></name>; <name><surname>Di Matteo</surname><given-names>A.</given-names></name>; <name><surname>Chiti</surname><given-names>F.</given-names></name>; <name><surname>Vitagliano</surname><given-names>L.</given-names></name>; <name><surname>Marasco</surname><given-names>D.</given-names></name>
<article-title>Nucleophosmin Contains Amyloidogenic Regions That Are
Able to Form Toxic Aggregates under Physiological Conditions</article-title>. <source>FASEB J.</source>
<year>2015</year>, <volume>29</volume> (<issue>9</issue>), <fpage>3689</fpage>&#x02013;<lpage>3701</lpage>. <pub-id pub-id-type="doi">10.1096/fj.14-269522</pub-id>.<pub-id pub-id-type="pmid">25977257</pub-id>
</mixed-citation></ref><ref id="ref51"><mixed-citation publication-type="journal" id="cit51"><name><surname>La
Manna</surname><given-names>S.</given-names></name>; <name><surname>Roviello</surname><given-names>V.</given-names></name>; <name><surname>Napolitano</surname><given-names>F.</given-names></name>; <name><surname>Malfitano</surname><given-names>A. M.</given-names></name>; <name><surname>Monaco</surname><given-names>V.</given-names></name>; <name><surname>Merlino</surname><given-names>A.</given-names></name>; <name><surname>Monti</surname><given-names>M.</given-names></name>; <name><surname>Kowalski</surname><given-names>K.</given-names></name>; <name><surname>Szczupak</surname><given-names>&#x00141;.</given-names></name>; <name><surname>Marasco</surname><given-names>D.</given-names></name>
<article-title>Metal-Complexes Bearing
Releasable CO Differently Modulate Amyloid Aggregation</article-title>. <source>Inorg. Chem.</source>
<year>2023</year>, <volume>62</volume> (<issue>26</issue>), <fpage>10470</fpage>&#x02013;<lpage>10480</lpage>. <pub-id pub-id-type="doi">10.1021/acs.inorgchem.3c01522</pub-id>.<pub-id pub-id-type="pmid">37338927</pub-id>
</mixed-citation></ref><ref id="ref52"><mixed-citation publication-type="journal" id="cit52"><name><surname>Han</surname><given-names>J.</given-names></name>; <name><surname>Gao</surname><given-names>X.</given-names></name>; <name><surname>Liu</surname><given-names>R.</given-names></name>; <name><surname>Yang</surname><given-names>J.</given-names></name>; <name><surname>Zhang</surname><given-names>M.</given-names></name>; <name><surname>Mi</surname><given-names>Y.</given-names></name>; <name><surname>Shi</surname><given-names>Y.</given-names></name>; <name><surname>Gao</surname><given-names>Q.</given-names></name>
<article-title>Design, Synthesis of Novel Platinum(II) Glycoconjugates,
and Evaluation of Their Antitumor Effects</article-title>. <source>Chem.
Biol. Drug Des</source>
<year>2016</year>, <volume>87</volume> (<issue>6</issue>), <fpage>867</fpage>&#x02013;<lpage>877</lpage>. <pub-id pub-id-type="doi">10.1111/cbdd.12718</pub-id>.<pub-id pub-id-type="pmid">26706102</pub-id>
</mixed-citation></ref><ref id="ref53"><mixed-citation publication-type="journal" id="cit53"><name><surname>Wang</surname><given-names>H.</given-names></name>; <name><surname>Yang</surname><given-names>X.</given-names></name>; <name><surname>Zhao</surname><given-names>C.</given-names></name>; <name><surname>Wang</surname><given-names>P. G.</given-names></name>; <name><surname>Wang</surname><given-names>X.</given-names></name>
<article-title>Glucose-Conjugated
Platinum(IV) Complexes as Tumor-Targeting Agents: Design, Synthesis
and Biological Evaluation</article-title>. <source>Bioorg. Med. Chem.</source>
<year>2019</year>, <volume>27</volume> (<issue>8</issue>), <fpage>1639</fpage>&#x02013;<lpage>1645</lpage>. <pub-id pub-id-type="doi">10.1016/j.bmc.2019.03.006</pub-id>.<pub-id pub-id-type="pmid">30852077</pub-id>
</mixed-citation></ref><ref id="ref54"><mixed-citation publication-type="journal" id="cit54"><name><surname>Annunziata</surname><given-names>A.</given-names></name>; <name><surname>Liberti</surname><given-names>D.</given-names></name>; <name><surname>Bedini</surname><given-names>E.</given-names></name>; <name><surname>Cucciolito</surname><given-names>M. E.</given-names></name>; <name><surname>Loreto</surname><given-names>D.</given-names></name>; <name><surname>Monti</surname><given-names>D. M.</given-names></name>; <name><surname>Merlino</surname><given-names>A.</given-names></name>; <name><surname>Ruffo</surname><given-names>F.</given-names></name>
<article-title>Square-Planar
vs. Trigonal Bipyramidal Geometry in Pt(II) Complexes Containing Triazole-Based
Glucose Ligands as Potential Anticancer Agents</article-title>. <source>IJMS</source>
<year>2021</year>, <volume>22</volume> (<issue>16</issue>), <fpage>8704</fpage><pub-id pub-id-type="doi">10.3390/ijms22168704</pub-id>.<pub-id pub-id-type="pmid">34445409</pub-id>
</mixed-citation></ref><ref id="ref55"><mixed-citation publication-type="journal" id="cit55"><name><surname>Annunziata</surname><given-names>A.</given-names></name>; <name><surname>Cucciolito</surname><given-names>M. E.</given-names></name>; <name><surname>Imbimbo</surname><given-names>P.</given-names></name>; <name><surname>Silipo</surname><given-names>A.</given-names></name>; <name><surname>Ruffo</surname><given-names>F.</given-names></name>
<article-title>A Hydrophilic
Olefin Pt(0) Complex Containing a Glucoconjugated 2-Iminopyridine
Ligand: Synthesis, Characterization, Stereochemistry and Biological
Activity</article-title>. <source>Inorg. Chim. Acta</source>
<year>2021</year>, <volume>516</volume>, <elocation-id>120092</elocation-id><pub-id pub-id-type="doi">10.1016/j.ica.2020.120092</pub-id>.</mixed-citation></ref><ref id="ref56"><mixed-citation publication-type="journal" id="cit56"><name><surname>La
Manna</surname><given-names>S.</given-names></name>; <name><surname>Leone</surname><given-names>M.</given-names></name>; <name><surname>Iacobucci</surname><given-names>I.</given-names></name>; <name><surname>Annuziata</surname><given-names>A.</given-names></name>; <name><surname>Di Natale</surname><given-names>C.</given-names></name>; <name><surname>Lagreca</surname><given-names>E.</given-names></name>; <name><surname>Malfitano</surname><given-names>A. M.</given-names></name>; <name><surname>Ruffo</surname><given-names>F.</given-names></name>; <name><surname>Merlino</surname><given-names>A.</given-names></name>; <name><surname>Monti</surname><given-names>M.</given-names></name>; <name><surname>Marasco</surname><given-names>D.</given-names></name>
<article-title>Glucosyl Platinum(II)
Complexes Inhibit Aggregation of the C-Terminal Region of the A&#x003b2;
Peptide</article-title>. <source>Inorg. Chem.</source>
<year>2022</year>, <volume>61</volume> (<issue>8</issue>), <fpage>3540</fpage>&#x02013;<lpage>3552</lpage>. <pub-id pub-id-type="doi">10.1021/acs.inorgchem.1c03540</pub-id>.<pub-id pub-id-type="pmid">35171608</pub-id>
</mixed-citation></ref><ref id="ref57"><mixed-citation publication-type="journal" id="cit57"><name><surname>Pettenuzzo</surname><given-names>A.</given-names></name>; <name><surname>Pigot</surname><given-names>R.</given-names></name>; <name><surname>Ronconi</surname><given-names>L.</given-names></name>
<article-title>Metal-Based
Glycoconjugates and Their
Potential in Targeted Anticancer Chemotherapy</article-title>. <source>Metallodrugs</source>
<year>2016</year>, <volume>1</volume> (<issue>1</issue>), <fpage>36</fpage><pub-id pub-id-type="doi">10.1515/medr-2015-0002</pub-id>.</mixed-citation></ref><ref id="ref58"><mixed-citation publication-type="journal" id="cit58"><name><surname>Annunziata</surname><given-names>A.</given-names></name>; <name><surname>Cucciolito</surname><given-names>M. E.</given-names></name>; <name><surname>Esposito</surname><given-names>R.</given-names></name>; <name><surname>Imbimbo</surname><given-names>P.</given-names></name>; <name><surname>Petruk</surname><given-names>G.</given-names></name>; <name><surname>Ferraro</surname><given-names>G.</given-names></name>; <name><surname>Pinto</surname><given-names>V.</given-names></name>; <name><surname>Tuzi</surname><given-names>A.</given-names></name>; <name><surname>Monti</surname><given-names>D. M.</given-names></name>; <name><surname>Merlino</surname><given-names>A.</given-names></name>; <name><surname>Ruffo</surname><given-names>F.</given-names></name>
<article-title>A Highly Efficient and Selective
Antitumor Agent Based on a Glucoconjugated Carbene Platinum(<sc>ii</sc>) Complex</article-title>. <source>Dalton Trans.</source>
<year>2019</year>, <volume>48</volume> (<issue>22</issue>), <fpage>7794</fpage>&#x02013;<lpage>7800</lpage>. <pub-id pub-id-type="doi">10.1039/C9DT01614G</pub-id>.<pub-id pub-id-type="pmid">31069352</pub-id>
</mixed-citation></ref><ref id="ref59"><mixed-citation publication-type="journal" id="cit59"><name><surname>Annunziata</surname><given-names>A.</given-names></name>; <name><surname>Amoresano</surname><given-names>A.</given-names></name>; <name><surname>Cucciolito</surname><given-names>M. E.</given-names></name>; <name><surname>Esposito</surname><given-names>R.</given-names></name>; <name><surname>Ferraro</surname><given-names>G.</given-names></name>; <name><surname>Iacobucci</surname><given-names>I.</given-names></name>; <name><surname>Imbimbo</surname><given-names>P.</given-names></name>; <name><surname>Lucignano</surname><given-names>R.</given-names></name>; <name><surname>Melchiorre</surname><given-names>M.</given-names></name>; <name><surname>Monti</surname><given-names>M.</given-names></name>; <name><surname>Scognamiglio</surname><given-names>C.</given-names></name>; <name><surname>Tuzi</surname><given-names>A.</given-names></name>; <name><surname>Monti</surname><given-names>D. M.</given-names></name>; <name><surname>Merlino</surname><given-names>A.</given-names></name>; <name><surname>Ruffo</surname><given-names>F.</given-names></name>
<article-title>Pt(II) versus
Pt(IV) in Carbene Glycoconjugate Antitumor Agents: Minimal Structural
Variations and Great Performance Changes</article-title>. <source>Inorg.
Chem.</source>
<year>2020</year>, <volume>59</volume> (<issue>6</issue>), <fpage>4002</fpage>&#x02013;<lpage>4014</lpage>. <pub-id pub-id-type="doi">10.1021/acs.inorgchem.9b03683</pub-id>.<pub-id pub-id-type="pmid">32129608</pub-id>
</mixed-citation></ref><ref id="ref60"><mixed-citation publication-type="journal" id="cit60"><name><surname>Annunziata</surname><given-names>A.</given-names></name>; <name><surname>Imbimbo</surname><given-names>P.</given-names></name>; <name><surname>Cucciolito</surname><given-names>M. E.</given-names></name>; <name><surname>Ferraro</surname><given-names>G.</given-names></name>; <name><surname>Langellotti</surname><given-names>V.</given-names></name>; <name><surname>Marano</surname><given-names>A.</given-names></name>; <name><surname>Melchiorre</surname><given-names>M.</given-names></name>; <name><surname>Tito</surname><given-names>G.</given-names></name>; <name><surname>Trifuoggi</surname><given-names>M.</given-names></name>; <name><surname>Monti</surname><given-names>D. M.</given-names></name>; <name><surname>Merlino</surname><given-names>A.</given-names></name>; <name><surname>Ruffo</surname><given-names>F.</given-names></name>
<article-title>Impact of Hydrophobic
Chains in Five-Coordinate Glucoconjugate Pt(II) Anticancer Agents</article-title>. <source>Int. J. Mol. Sci.</source>
<year>2023</year>, <volume>24</volume> (<issue>3</issue>), <fpage>2369</fpage><pub-id pub-id-type="doi">10.3390/ijms24032369</pub-id>.<pub-id pub-id-type="pmid">36768690</pub-id>
</mixed-citation></ref><ref id="ref61"><mixed-citation publication-type="journal" id="cit61"><name><surname>Tresin</surname><given-names>F.</given-names></name>; <name><surname>Stoppa</surname><given-names>V.</given-names></name>; <name><surname>Baron</surname><given-names>M.</given-names></name>; <name><surname>Biffis</surname><given-names>A.</given-names></name>; <name><surname>Annunziata</surname><given-names>A.</given-names></name>; <name><surname>D&#x02019;Elia</surname><given-names>L.</given-names></name>; <name><surname>Monti</surname><given-names>D. M.</given-names></name>; <name><surname>Ruffo</surname><given-names>F.</given-names></name>; <name><surname>Roverso</surname><given-names>M.</given-names></name>; <name><surname>Sgarbossa</surname><given-names>P.</given-names></name>; <name><surname>Bogialli</surname><given-names>S.</given-names></name>; <name><surname>Tubaro</surname><given-names>C.</given-names></name>
<article-title>Synthesis and Biological
Studies on Dinuclear Gold(I) Complexes with Di-(N-Heterocyclic Carbene)
Ligands Functionalized with Carbohydrates</article-title>. <source>Molecules</source>
<year>2020</year>, <volume>25</volume> (<issue>17</issue>), <fpage>3850</fpage><pub-id pub-id-type="doi">10.3390/molecules25173850</pub-id>.<pub-id pub-id-type="pmid">32847116</pub-id>
</mixed-citation></ref><ref id="ref62"><mixed-citation publication-type="journal" id="cit62"><name><surname>Annunziata</surname><given-names>A.</given-names></name>; <name><surname>Ferraro</surname><given-names>G.</given-names></name>; <name><surname>Cucciolito</surname><given-names>M. E.</given-names></name>; <name><surname>Imbimbo</surname><given-names>P.</given-names></name>; <name><surname>Tuzi</surname><given-names>A.</given-names></name>; <name><surname>Monti</surname><given-names>D. M.</given-names></name>; <name><surname>Merlino</surname><given-names>A.</given-names></name>; <name><surname>Ruffo</surname><given-names>F.</given-names></name>
<article-title>Halo Complexes of Gold(<sc>i</sc>) Containing Glycoconjugate Carbene
Ligands: Synthesis, Characterization,
Cytotoxicity and Interaction with Proteins and DNA Model Systems</article-title>. <source>Dalton Trans.</source>
<year>2022</year>, <volume>51</volume> (<issue>27</issue>), <fpage>10475</fpage>&#x02013;<lpage>10485</lpage>. <pub-id pub-id-type="doi">10.1039/D2DT00423B</pub-id>.<pub-id pub-id-type="pmid">35766118</pub-id>
</mixed-citation></ref><ref id="ref63"><mixed-citation publication-type="journal" id="cit63"><name><surname>Annunziata</surname><given-names>A.</given-names></name>; <name><surname>Cucciolito</surname><given-names>M. E.</given-names></name>; <name><surname>Di Ronza</surname><given-names>M.</given-names></name>; <name><surname>Ferraro</surname><given-names>G.</given-names></name>; <name><surname>Hadiji</surname><given-names>M.</given-names></name>; <name><surname>Merlino</surname><given-names>A.</given-names></name>; <name><surname>Ortiz</surname><given-names>D.</given-names></name>; <name><surname>Scopelliti</surname><given-names>R.</given-names></name>; <name><surname>Fadaei Tirani</surname><given-names>F.</given-names></name>; <name><surname>Dyson</surname><given-names>P. J.</given-names></name>; <name><surname>Ruffo</surname><given-names>F.</given-names></name>
<article-title>Ruthenium(II)&#x02013;Arene
Complexes with Glycosylated NHC-Carbene Co-Ligands: Synthesis, Hydrolytic
Behavior, and Binding to Biological Molecules</article-title>. <source>Organometallics</source>
<year>2023</year>, <volume>42</volume> (<issue>10</issue>), <fpage>952</fpage>&#x02013;<lpage>964</lpage>. <pub-id pub-id-type="doi">10.1021/acs.organomet.3c00128</pub-id>.</mixed-citation></ref><ref id="ref64"><mixed-citation publication-type="journal" id="cit64"><name><surname>Annunziata</surname><given-names>A.</given-names></name>; <name><surname>Cucciolito</surname><given-names>M. E.</given-names></name>; <name><surname>Esposito</surname><given-names>R.</given-names></name>; <name><surname>Traboni</surname><given-names>S.</given-names></name>; <name><surname>Tuzi</surname><given-names>A.</given-names></name>; <name><surname>Budzelaar</surname><given-names>P. H. M.</given-names></name>; <name><surname>Ruffo</surname><given-names>F.</given-names></name>
<article-title>Oxidative Addition of &#x003b1;-Glycosyl
Halides to a Platinum(0) Olefin Complex: Stereochemistry of Pt&#x02013;C
Bond Formation</article-title>. <source>Eur. J. Inorg. Chem.</source>
<year>2021</year>, <volume>2021</volume> (<issue>6</issue>), <fpage>534</fpage>&#x02013;<lpage>539</lpage>. <pub-id pub-id-type="doi">10.1002/ejic.202001088</pub-id>.</mixed-citation></ref><ref id="ref65"><mixed-citation publication-type="journal" id="cit65"><name><surname>Castarlenas</surname><given-names>R.</given-names></name>; <name><surname>Esteruelas</surname><given-names>M. A.</given-names></name>; <name><surname>O&#x000f1;ate</surname><given-names>E.</given-names></name>
<article-title>N-Heterocyclic Carbene&#x02013;Osmium
Complexes for Olefin Metathesis Reactions</article-title>. <source>Organometallics</source>
<year>2005</year>, <volume>24</volume> (<issue>18</issue>), <fpage>4343</fpage>&#x02013;<lpage>4346</lpage>. <pub-id pub-id-type="doi">10.1021/om050569e</pub-id>.</mixed-citation></ref><ref id="ref66"><mixed-citation publication-type="journal" id="cit66"><name><surname>Jantke</surname><given-names>D.</given-names></name>; <name><surname>Cokoja</surname><given-names>M.</given-names></name>; <name><surname>P&#x000f6;thig</surname><given-names>A.</given-names></name>; <name><surname>Herrmann</surname><given-names>W. A.</given-names></name>; <name><surname>K&#x000fc;hn</surname><given-names>F. E.</given-names></name>
<article-title>Synthesis
and Characterization of Highly Water Soluble Ruthenium(II) and Osmium(II)
Complexes Bearing Chelating Sulfonated N-Heterocyclic Carbene Ligands</article-title>. <source>Organometallics</source>
<year>2013</year>, <volume>32</volume> (<issue>3</issue>), <fpage>741</fpage>&#x02013;<lpage>744</lpage>. <pub-id pub-id-type="doi">10.1021/om301218k</pub-id>.</mixed-citation></ref><ref id="ref67"><mixed-citation publication-type="journal" id="cit67"><name><surname>Mignon</surname><given-names>J.</given-names></name>; <name><surname>Leyder</surname><given-names>T.</given-names></name>; <name><surname>Mottet</surname><given-names>D.</given-names></name>; <name><surname>Uversky</surname><given-names>V. N.</given-names></name>; <name><surname>Michaux</surname><given-names>C.</given-names></name>
<article-title>In-Depth Investigation
of the Effect of pH on the Autofluorescence Properties of DPF3b and
DPF3a Amyloid Fibrils</article-title>. <source>Spectrochimica Acta Part
A: Molecular and Biomolecular Spectroscopy</source>
<year>2024</year>, <volume>313</volume>, <elocation-id>124156</elocation-id><pub-id pub-id-type="doi">10.1016/j.saa.2024.124156</pub-id>.<pub-id pub-id-type="pmid">38508075</pub-id>
</mixed-citation></ref><ref id="ref68"><mixed-citation publication-type="journal" id="cit68"><name><surname>Grummitt</surname><given-names>C. G.</given-names></name>; <name><surname>Townsley</surname><given-names>F. M.</given-names></name>; <name><surname>Johnson</surname><given-names>C. M.</given-names></name>; <name><surname>Warren</surname><given-names>A. J.</given-names></name>; <name><surname>Bycroft</surname><given-names>M.</given-names></name>
<article-title>Structural
Consequences of Nucleophosmin Mutations in Acute Myeloid Leukemia*</article-title>. <source>J. Biol. Chem.</source>
<year>2008</year>, <volume>283</volume> (<issue>34</issue>), <fpage>23326</fpage>&#x02013;<lpage>23332</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M801706200</pub-id>.<pub-id pub-id-type="pmid">18511415</pub-id>
</mixed-citation></ref><ref id="ref69"><mixed-citation publication-type="journal" id="cit69"><name><surname>Florio</surname><given-names>D.</given-names></name>; <name><surname>Luciano</surname><given-names>P.</given-names></name>; <name><surname>Di Natale</surname><given-names>C.</given-names></name>; <name><surname>Marasco</surname><given-names>D.</given-names></name>
<article-title>The Effects of Histidine
Substitution of Aromatic Residues on the Amyloidogenic Properties
of the Fragment 264&#x02013;277 of Nucleophosmin 1</article-title>. <source>Bioorganic Chemistry</source>
<year>2024</year>, <volume>147</volume>, <elocation-id>107404</elocation-id><pub-id pub-id-type="doi">10.1016/j.bioorg.2024.107404</pub-id>.<pub-id pub-id-type="pmid">38678777</pub-id>
</mixed-citation></ref><ref id="ref70"><mixed-citation publication-type="journal" id="cit70"><name><surname>Yang</surname><given-names>H.</given-names></name>; <name><surname>Yang</surname><given-names>S.</given-names></name>; <name><surname>Kong</surname><given-names>J.</given-names></name>; <name><surname>Dong</surname><given-names>A.</given-names></name>; <name><surname>Yu</surname><given-names>S.</given-names></name>
<article-title>Obtaining
Information about Protein Secondary Structures in Aqueous Solution
Using Fourier Transform IR Spectroscopy</article-title>. <source>Nat.
Protoc.</source>
<year>2015</year>, <volume>10</volume> (<issue>3</issue>), <fpage>382</fpage>&#x02013;<lpage>396</lpage>. <pub-id pub-id-type="doi">10.1038/nprot.2015.024</pub-id>.<pub-id pub-id-type="pmid">25654756</pub-id>
</mixed-citation></ref><ref id="ref71"><mixed-citation publication-type="journal" id="cit71"><name><surname>Urmey</surname><given-names>A. R.</given-names></name>; <name><surname>Zondlo</surname><given-names>N. J.</given-names></name>
<article-title>Cysteine Oxidation to the Sulfinic Acid Induces Oxoform-Specific
Lanthanide Binding and Fluorescence in a Designed Peptide</article-title>. <source>Free Radical Biol. Med.</source>
<year>2020</year>, <volume>152</volume>, <fpage>166</fpage>&#x02013;<lpage>174</lpage>. <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2020.02.020</pub-id>.<pub-id pub-id-type="pmid">32097680</pub-id>
</mixed-citation></ref><ref id="ref72"><mixed-citation publication-type="journal" id="cit72"><name><surname>Lim</surname><given-names>J. C.</given-names></name>; <name><surname>Choi</surname><given-names>H.-I.</given-names></name>; <name><surname>Park</surname><given-names>Y. S.</given-names></name>; <name><surname>Nam</surname><given-names>H. W.</given-names></name>; <name><surname>Woo</surname><given-names>H. A.</given-names></name>; <name><surname>Kwon</surname><given-names>K.-S.</given-names></name>; <name><surname>Kim</surname><given-names>Y. S.</given-names></name>; <name><surname>Rhee</surname><given-names>S. G.</given-names></name>; <name><surname>Kim</surname><given-names>K.</given-names></name>; <name><surname>Chae</surname><given-names>H. Z.</given-names></name>
<article-title>Irreversible Oxidation
of the Active-Site Cysteine
of Peroxiredoxin to Cysteine Sulfonic Acid for Enhanced Molecular
Chaperone Activity&#x02217;</article-title>. <source>J. Biol. Chem.</source>
<year>2008</year>, <volume>283</volume> (<issue>43</issue>), <fpage>28873</fpage>&#x02013;<lpage>28880</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M804087200</pub-id>.<pub-id pub-id-type="pmid">18725414</pub-id>
</mixed-citation></ref><ref id="ref73"><mixed-citation publication-type="journal" id="cit73"><name><surname>Florio</surname><given-names>D.</given-names></name>; <name><surname>Roviello</surname><given-names>V.</given-names></name>; <name><surname>La Manna</surname><given-names>S.</given-names></name>; <name><surname>Napolitano</surname><given-names>F.</given-names></name>; <name><surname>Maria Malfitano</surname><given-names>A.</given-names></name>; <name><surname>Marasco</surname><given-names>D.</given-names></name>
<article-title>Small Molecules Enhancers of Amyloid
Aggregation of C-Terminal Domain of Nucleophosmin 1 in Acute Myeloid
Leukemia</article-title>. <source>Bioorganic Chemistry</source>
<year>2022</year>, <volume>127</volume>, <elocation-id>106001</elocation-id><pub-id pub-id-type="doi">10.1016/j.bioorg.2022.106001</pub-id>.<pub-id pub-id-type="pmid">35803020</pub-id>
</mixed-citation></ref><ref id="ref74"><mixed-citation publication-type="journal" id="cit74"><name><surname>Ni</surname><given-names>W.-X.</given-names></name>; <name><surname>Man</surname><given-names>W.-L.</given-names></name>; <name><surname>Yiu</surname><given-names>S.-M.</given-names></name>; <name><surname>Ho</surname><given-names>M.</given-names></name>; <name><surname>Cheung</surname><given-names>M. T.-W.</given-names></name>; <name><surname>Ko</surname><given-names>C.-C.</given-names></name>; <name><surname>Che</surname><given-names>C.-M.</given-names></name>; <name><surname>Lam</surname><given-names>Y.-W.</given-names></name>; <name><surname>Lau</surname><given-names>T.-C.</given-names></name>
<article-title>Osmium(vi)
Nitrido Complexes Bearing Azole Heterocycles: A New Class of Antitumor
Agents</article-title>. <source>Chem. Sci.</source>
<year>2012</year>, <volume>3</volume> (<issue>5</issue>), <fpage>1582</fpage>&#x02013;<lpage>1588</lpage>. <pub-id pub-id-type="doi">10.1039/c2sc01031c</pub-id>.</mixed-citation></ref><ref id="ref75"><mixed-citation publication-type="journal" id="cit75"><name><surname>M&#x000fc;hlgassner</surname><given-names>G.</given-names></name>; <name><surname>Bartel</surname><given-names>C.</given-names></name>; <name><surname>Schmid</surname><given-names>W. F.</given-names></name>; <name><surname>Jakupec</surname><given-names>M. A.</given-names></name>; <name><surname>Arion</surname><given-names>V. B.</given-names></name>; <name><surname>Keppler</surname><given-names>B. K.</given-names></name>
<article-title>Biological Activity
of Ruthenium and Osmium Arene Complexes
with Modified Paullones in Human Cancer Cells</article-title>. <source>Journal of Inorganic Biochemistry</source>
<year>2012</year>, <volume>116</volume>, <fpage>180</fpage>&#x02013;<lpage>187</lpage>. <pub-id pub-id-type="doi">10.1016/j.jinorgbio.2012.06.003</pub-id>.<pub-id pub-id-type="pmid">23037896</pub-id>
</mixed-citation></ref><ref id="ref76"><mixed-citation publication-type="journal" id="cit76"><name><surname>Josa</surname><given-names>D.</given-names></name>; <name><surname>Aguil&#x000e0;</surname><given-names>D.</given-names></name>; <name><surname>Fontova</surname><given-names>P.</given-names></name>; <name><surname>Soto-Cerrato</surname><given-names>V.</given-names></name>; <name><surname>Herrera-Ram&#x000ed;rez</surname><given-names>P.</given-names></name>; <name><surname>Rafols</surname><given-names>L.</given-names></name>; <name><surname>Grabulosa</surname><given-names>A.</given-names></name>; <name><surname>Gamez</surname><given-names>P.</given-names></name>
<article-title>Cytotoxicity of Osmium(Ii)
and Cycloosmated Half-Sandwich Complexes
from 1-Pyrenyl-Containing Phosphane Ligands</article-title>. <source>Dalton Trans.</source>
<year>2023</year>, <volume>52</volume> (<issue>24</issue>), <fpage>8391</fpage>&#x02013;<lpage>8401</lpage>. <pub-id pub-id-type="doi">10.1039/D3DT00743J</pub-id>.<pub-id pub-id-type="pmid">37265269</pub-id>
</mixed-citation></ref><ref id="ref77"><mixed-citation publication-type="journal" id="cit77"><name><surname>Crochet</surname><given-names>P.</given-names></name>; <name><surname>Cadierno</surname><given-names>V.</given-names></name>
<article-title>Arene-Osmium(II) Complexes
in Homogeneous Catalysis</article-title>. <source>Inorganics</source>
<year>2021</year>, <volume>9</volume> (<issue>7</issue>), <fpage>55</fpage><pub-id pub-id-type="doi">10.3390/inorganics9070055</pub-id>.</mixed-citation></ref><ref id="ref78"><mixed-citation publication-type="journal" id="cit78"><name><surname>Marshall</surname><given-names>K. E.</given-names></name>; <name><surname>Vadukul</surname><given-names>D. M.</given-names></name>; <name><surname>Dahal</surname><given-names>L.</given-names></name>; <name><surname>Theisen</surname><given-names>A.</given-names></name>; <name><surname>Fowler</surname><given-names>M. W.</given-names></name>; <name><surname>Al-Hilaly</surname><given-names>Y.</given-names></name>; <name><surname>Ford</surname><given-names>L.</given-names></name>; <name><surname>Kemenes</surname><given-names>G.</given-names></name>; <name><surname>Day</surname><given-names>I. J.</given-names></name>; <name><surname>Staras</surname><given-names>K.</given-names></name>; <name><surname>Serpell</surname><given-names>L. C.</given-names></name>
<article-title>A Critical Role for the Self-Assembly
of Amyloid-&#x00392;1&#x02013;42 in Neurodegeneration</article-title>. <source>Sci. Rep.</source>
<year>2016</year>, <volume>6</volume> (<issue>1</issue>), <fpage>30182</fpage><pub-id pub-id-type="doi">10.1038/srep30182</pub-id>.<pub-id pub-id-type="pmid">27443509</pub-id>
</mixed-citation></ref><ref id="ref79"><mixed-citation publication-type="journal" id="cit79"><name><surname>La
Manna</surname><given-names>S.</given-names></name>; <name><surname>Florio</surname><given-names>D.</given-names></name>; <name><surname>Di Natale</surname><given-names>C.</given-names></name>; <name><surname>Napolitano</surname><given-names>F.</given-names></name>; <name><surname>Malfitano</surname><given-names>A. M.</given-names></name>; <name><surname>Netti</surname><given-names>P. A.</given-names></name>; <name><surname>De Benedictis</surname><given-names>I.</given-names></name>; <name><surname>Marasco</surname><given-names>D.</given-names></name>
<article-title>Conformational Consequences of NPM1 Rare Mutations:
An Aggregation Perspective in Acute Myeloid Leukemia</article-title>. <source>Bioorganic Chemistry</source>
<year>2021</year>, <volume>113</volume>, <elocation-id>104997</elocation-id><pub-id pub-id-type="doi">10.1016/j.bioorg.2021.104997</pub-id>.<pub-id pub-id-type="pmid">34044346</pub-id>
</mixed-citation></ref><ref id="ref80"><mixed-citation publication-type="journal" id="cit80"><name><surname>La
Manna</surname><given-names>S.</given-names></name>; <name><surname>Florio</surname><given-names>D.</given-names></name>; <name><surname>Di Natale</surname><given-names>C.</given-names></name>; <name><surname>Lagreca</surname><given-names>E.</given-names></name>; <name><surname>Sibillano</surname><given-names>T.</given-names></name>; <name><surname>Giannini</surname><given-names>C.</given-names></name>; <name><surname>Marasco</surname><given-names>D.</given-names></name>
<article-title>Type C Mutation
of Nucleophosmin 1 Acute Myeloid Leukemia: Consequences of Intrinsic
Disorder</article-title>. <source>Biochimica et Biophysica Acta (BBA)
- General Subjects</source>
<year>2022</year>, <volume>1866</volume> (<issue>8</issue>), <elocation-id>130173</elocation-id><pub-id pub-id-type="doi">10.1016/j.bbagen.2022.130173</pub-id>.<pub-id pub-id-type="pmid">35597503</pub-id>
</mixed-citation></ref><ref id="ref81"><mixed-citation publication-type="journal" id="cit81"><name><surname>Chiarella</surname><given-names>S.</given-names></name>; <name><surname>De Cola</surname><given-names>A.</given-names></name>; <name><surname>Scaglione</surname><given-names>G. L.</given-names></name>; <name><surname>Carletti</surname><given-names>E.</given-names></name>; <name><surname>Graziano</surname><given-names>V.</given-names></name>; <name><surname>Barcaroli</surname><given-names>D.</given-names></name>; <name><surname>Lo Sterzo</surname><given-names>C.</given-names></name>; <name><surname>Di Matteo</surname><given-names>A.</given-names></name>; <name><surname>Di Ilio</surname><given-names>C.</given-names></name>; <name><surname>Falini</surname><given-names>B.</given-names></name>; <name><surname>Arcovito</surname><given-names>A.</given-names></name>; <name><surname>De Laurenzi</surname><given-names>V.</given-names></name>; <name><surname>Federici</surname><given-names>L.</given-names></name>
<article-title>Nucleophosmin Mutations
Alter Its Nucleolar Localization
by Impairing G-Quadruplex Binding at Ribosomal DNA</article-title>. <source>Nucleic Acids Res.</source>
<year>2013</year>, <volume>41</volume> (<issue>5</issue>), <fpage>3228</fpage>&#x02013;<lpage>3239</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkt001</pub-id>.<pub-id pub-id-type="pmid">23328624</pub-id>
</mixed-citation></ref><ref id="ref82"><mixed-citation publication-type="journal" id="cit82"><name><surname>La
Manna</surname><given-names>S.</given-names></name>; <name><surname>Florio</surname><given-names>D.</given-names></name>; <name><surname>Di Natale</surname><given-names>C.</given-names></name>; <name><surname>Scognamiglio</surname><given-names>P. L.</given-names></name>; <name><surname>Sibillano</surname><given-names>T.</given-names></name>; <name><surname>Netti</surname><given-names>P. A.</given-names></name>; <name><surname>Giannini</surname><given-names>C.</given-names></name>; <name><surname>Marasco</surname><given-names>D.</given-names></name>
<article-title>Type F Mutation of Nucleophosmin 1 Acute Myeloid Leukemia:
A Tale of Disorder and Aggregation</article-title>. <source>Int. J.
Biol. Macromol.</source>
<year>2021</year>, <volume>188</volume>, <fpage>207</fpage>&#x02013;<lpage>214</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2021.08.023</pub-id>.<pub-id pub-id-type="pmid">34364939</pub-id>
</mixed-citation></ref><ref id="ref83"><mixed-citation publication-type="journal" id="cit83"><name><surname>Vigueras</surname><given-names>G.</given-names></name>; <name><surname>Sabate</surname><given-names>R.</given-names></name>; <name><surname>Barrios</surname><given-names>L. A.</given-names></name>; <name><surname>Caballero</surname><given-names>A. B.</given-names></name>; <name><surname>Hern&#x000e1;ndez-Garc&#x000ed;a</surname><given-names>S.</given-names></name>; <name><surname>Bay&#x000f3;n</surname><given-names>P.</given-names></name>; <name><surname>Gand&#x000ed;a-Herrero</surname><given-names>F.</given-names></name>; <name><surname>Ruiz</surname><given-names>J.</given-names></name>; <name><surname>Gamez</surname><given-names>P.</given-names></name>
<article-title>Piano-Stool
Metal Complexes as Inhibitors of Amyloid-&#x003b2; Aggregation in Vitro
and in Vivo</article-title>. <source>Inorg. Chem. Front.</source>
<year>2024</year>, <volume>11</volume> (<issue>18</issue>), <fpage>6089</fpage>&#x02013;<lpage>6102</lpage>. <pub-id pub-id-type="doi">10.1039/D4QI01460J</pub-id>.</mixed-citation></ref><ref id="ref84"><mixed-citation publication-type="journal" id="cit84"><name><surname>Soldevila-Barreda</surname><given-names>J. J.</given-names></name>; <name><surname>Pettenuzzo</surname><given-names>A.</given-names></name>; <name><surname>Azmanova</surname><given-names>M.</given-names></name>; <name><surname>Rafols</surname><given-names>L.</given-names></name>; <name><surname>Attia</surname><given-names>A. A. A.</given-names></name>; <name><surname>Lupan</surname><given-names>A.</given-names></name>; <name><surname>Ronconi</surname><given-names>L.</given-names></name>; <name><surname>Barry</surname><given-names>N. P. E.</given-names></name>; <name><surname>Pitto-Barry</surname><given-names>A.</given-names></name>
<article-title>Synthesis,
Characterisation, and in Vitro Cytotoxic Activity of Dithiocarbamato
Glycoconjugate Half-Sandwich Ruthenium and Osmium Complexes</article-title>. <source>Helv. Chim. Acta</source>
<year>2023</year>, <volume>106</volume> (<issue>8</issue>), <elocation-id>e202300064</elocation-id><pub-id pub-id-type="doi">10.1002/hlca.202300064</pub-id>.</mixed-citation></ref><ref id="ref85"><mixed-citation publication-type="journal" id="cit85"><name><surname>Micsonai</surname><given-names>A.</given-names></name>; <name><surname>Wien</surname><given-names>F.</given-names></name>; <name><surname>Kernya</surname><given-names>L.</given-names></name>; <name><surname>Lee</surname><given-names>Y.-H.</given-names></name>; <name><surname>Goto</surname><given-names>Y.</given-names></name>; <name><surname>R&#x000e9;fr&#x000e9;giers</surname><given-names>M.</given-names></name>; <name><surname>Kardos</surname><given-names>J.</given-names></name>
<article-title>Accurate Secondary
Structure Prediction and Fold Recognition for Circular Dichroism Spectroscopy</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source>
<year>2015</year>, <volume>112</volume> (<issue>24</issue>), <fpage>E3095</fpage>&#x02013;<lpage>E3103</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1500851112</pub-id>.<pub-id pub-id-type="pmid">26038575</pub-id>
</mixed-citation></ref></ref-list></back></article>